Year |
Citation |
Score |
2024 |
Li XQ, Yamazaki T, He T, Alam MM, Liu J, Trivett AL, Sveinbjørnsson B, Rekdal Ø, Galluzzi L, Oppenheim JJ, Yang D. LTX-315 triggers anticancer immunity by inducing MyD88-dependent maturation of dendritic cells. Frontiers in Immunology. 15: 1332922. PMID 38545099 DOI: 10.3389/fimmu.2024.1332922 |
0.334 |
|
2024 |
Chen X, Tsvetkov AS, Shen HM, Isidoro C, Ktistakis NT, Linkermann A, Koopman WJH, Simon HU, Galluzzi L, Luo S, Xu D, Gu W, Peulen O, Cai Q, Rubinsztein DC, et al. International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis. Autophagy. PMID 38442890 DOI: 10.1080/15548627.2024.2319901 |
0.442 |
|
2024 |
Dai E, Chen X, Linkermann A, Jiang X, Kang R, Kagan VE, Bayir H, Yang WS, Garcia-Saez AJ, Ioannou MS, Janowitz T, Ran Q, Gu W, Gan B, Krysko DV, ... ... Galluzzi L, et al. A guideline on the molecular ecosystem regulating ferroptosis. Nature Cell Biology. PMID 38424270 DOI: 10.1038/s41556-024-01360-8 |
0.365 |
|
2023 |
Kroemer G, Chan TA, Eggermont AMM, Galluzzi L. Immunosurveillance in clinical cancer management. Ca: a Cancer Journal For Clinicians. PMID 37880100 DOI: 10.3322/caac.21818 |
0.463 |
|
2023 |
Kepp O, Liu P, Kroemer G, Galluzzi L. A mitochondrial checkpoint to adaptive anticancer immunity. Oncoimmunology. 12: 2271693. PMID 37860277 DOI: 10.1080/2162402X.2023.2271693 |
0.438 |
|
2023 |
Galassi C, Klapp V, Yamazaki T, Galluzzi L. Molecular determinants of immunogenic cell death elicited by radiation therapy. Immunological Reviews. PMID 37679959 DOI: 10.1111/imr.13271 |
0.351 |
|
2023 |
Zhao L, Liu P, Mao M, Zhang S, Bigenwald C, Dutertre CA, Lehmann CHK, Pan H, Paulhan N, Amon L, Buque A, Yamazaki T, Galluzzi L, Kloeckner B, Silvin A, et al. BCL2 inhibition reveals a dendritic cell-specific immune checkpoint that controls tumor immunosurveillance. Cancer Discovery. PMID 37623817 DOI: 10.1158/2159-8290.CD-22-1338 |
0.419 |
|
2023 |
Cultrara C, Uhl C, Kirby K, Abed Elrazaq E, Zellander A, Andrews DW, Scott CB, Galluzzi L, Exley MA, Zilberberg J. A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma. Journal For Immunotherapy of Cancer. 11. PMID 37550054 DOI: 10.1136/jitc-2023-006880 |
0.302 |
|
2023 |
Galluzzi L, Myint M. Cell death and senescence. Journal of Translational Medicine. 21: 425. PMID 37386590 DOI: 10.1186/s12967-023-04297-y |
0.305 |
|
2023 |
Dhaouadi N, Vitto VAM, Pinton P, Galluzzi L, Marchi S. Ca signaling and cell death. Cell Calcium. 113: 102759. PMID 37210868 DOI: 10.1016/j.ceca.2023.102759 |
0.334 |
|
2023 |
Guilbaud E, Kroemer G, Galluzzi L. Calreticulin exposure orchestrates innate immunosurveillance. Cancer Cell. 41: 1014-1016. PMID 37207656 DOI: 10.1016/j.ccell.2023.04.015 |
0.352 |
|
2023 |
Vitale I, Pietrocola F, Guilbaud E, Aaronson SA, Abrams JM, Adam D, Agostini M, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Aqeilan RI, Arama E, Baehrecke EH, ... ... Galluzzi L, et al. Apoptotic cell death in disease-Current understanding of the NCCD 2023. Cell Death and Differentiation. PMID 37100955 DOI: 10.1038/s41418-023-01153-w |
0.703 |
|
2023 |
Klapp V, Álvarez-Abril B, Leuzzi G, Kroemer G, Ciccia A, Galluzzi L. The DNA Damage Response and Inflammation in Cancer. Cancer Discovery. OF1-OF25. PMID 37026695 DOI: 10.1158/2159-8290.CD-22-1220 |
0.437 |
|
2023 |
Galluzzi L, Kepp O, Hett E, Kroemer G, Marincola FM. Immunogenic cell death in cancer: concept and therapeutic implications. Journal of Translational Medicine. 21: 162. PMID 36864446 DOI: 10.1186/s12967-023-04017-6 |
0.518 |
|
2023 |
López-Otín C, Pietrocola F, Roiz-Valle D, Galluzzi L, Kroemer G. Meta-hallmarks of aging and cancer. Cell Metabolism. 35: 12-35. PMID 36599298 DOI: 10.1016/j.cmet.2022.11.001 |
0.635 |
|
2022 |
Tong L, Jiménez-Cortegana C, Tay AHM, Wickström S, Galluzzi L, Lundqvist A. NK cells and solid tumors: therapeutic potential and persisting obstacles. Molecular Cancer. 21: 206. PMID 36319998 DOI: 10.1186/s12943-022-01672-z |
0.346 |
|
2022 |
Galluzzi L, Kroemer G. Calreticulin surface presentation can promote quality control of hematopoietic stem cells. Trends in Immunology. PMID 36307308 DOI: 10.1016/j.it.2022.10.008 |
0.379 |
|
2022 |
Álvarez-Abril B, Bloy N, Galassi C, Sato A, Jiménez-Cortegana C, Klapp V, Aretz A, Guilbaud E, Buqué A, Galluzzi L, Yamazaki T. Cytofluorometric assessment of acute cell death responses driven by radiation therapy. Methods in Cell Biology. 172: 17-36. PMID 36064223 DOI: 10.1016/bs.mcb.2022.05.002 |
0.322 |
|
2022 |
Galassi C, Ruan Y, Sato A, Jiménez-Cortegana C, Klapp V, Bloy N, Guilbaud E, Petroni G, Buqué A, Galluzzi L, Yamazaki T. RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells. Methods in Cell Biology. 172: 145-161. PMID 36064221 DOI: 10.1016/bs.mcb.2022.05.005 |
0.321 |
|
2022 |
Jiménez-Cortegana C, Klapp V, Bloy N, Galassi C, Sato A, Yamazaki T, Buqué A, Galluzzi L, Petroni G. Cytofluorometric assessment of cell cycle progression in irradiated cells. Methods in Cell Biology. 172: 1-16. PMID 36064218 DOI: 10.1016/bs.mcb.2021.12.025 |
0.354 |
|
2022 |
Galluzzi L, Kroemer G. Immuno-epigenetic escape of cancer stem cells. Nature Immunology. 23: 1300-1302. PMID 36002649 DOI: 10.1038/s41590-022-01293-0 |
0.367 |
|
2022 |
Le Naour J, Sztupinszki Z, Carbonnier V, Casiraghi O, Marty V, Galluzzi L, Szallasi Z, Kroemer G, Vacchelli E. A loss-of-function polymorphism in compromises therapeutic outcome in head and neck carcinoma patients. Oncoimmunology. 11: 2059878. PMID 35481288 DOI: 10.1080/2162402X.2022.2059878 |
0.679 |
|
2022 |
Jiménez-Cortegana C, Galassi C, Klapp V, Gabrilovich DI, Galluzzi L. Myeloid-Derived Suppressor Cells and Radiotherapy. Cancer Immunology Research. 10: 545-557. PMID 35426936 DOI: 10.1158/2326-6066.CIR-21-1105 |
0.32 |
|
2022 |
Fucikova J, Palova-Jelinkova L, Klapp V, Holicek P, Lanickova T, Kasikova L, Drozenova J, Cibula D, Álvarez-Abril B, García-Martínez E, Spisek R, Galluzzi L. Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents. Trends in Cancer. PMID 35181272 DOI: 10.1016/j.trecan.2022.01.010 |
0.335 |
|
2022 |
Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nature Immunology. PMID 35145297 DOI: 10.1038/s41590-022-01132-2 |
0.49 |
|
2021 |
Petroni G, Cantley LC, Santambrogio L, Formenti SC, Galluzzi L. Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer. Nature Reviews. Clinical Oncology. PMID 34819622 DOI: 10.1038/s41571-021-00579-w |
0.325 |
|
2021 |
Humeau J, Le Naour J, Galluzzi L, Kroemer G, Pol JG. Trial watch: intratumoral immunotherapy. Oncoimmunology. 10: 1984677. PMID 34676147 DOI: 10.1080/2162402X.2021.1984677 |
0.479 |
|
2021 |
Klionsky DJ, Petroni G, Amaravadi RK, Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cadwell K, Cecconi F, Choi AMK, Choi ME, Chu CT, Codogno P, Colombo MI, Cuervo AM, ... ... Galluzzi L, et al. Autophagy in major human diseases. The Embo Journal. e108863. PMID 34459017 DOI: 10.15252/embj.2021108863 |
0.651 |
|
2021 |
Kepp O, Bezu L, Yamazaki T, Di Virgilio F, Smyth MJ, Kroemer G, Galluzzi L. ATP and cancer immunosurveillance. The Embo Journal. e108130. PMID 34121201 DOI: 10.15252/embj.2021108130 |
0.399 |
|
2021 |
Galluzzi L, Garg AD. Immunology of Cell Death in Cancer Immunotherapy. Cells. 10. PMID 34063358 DOI: 10.3390/cells10051208 |
0.352 |
|
2021 |
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, ... ... Galluzzi L, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 1-382. PMID 33634751 DOI: 10.1080/15548627.2020.1797280 |
0.804 |
|
2021 |
Buqué A, Galluzzi L, Kroemer G. Ketosis versus carbotoxicity - metabolism determines the outcome of cancer immunotherapy. Molecular & Cellular Oncology. 8: 1868266. PMID 33553614 DOI: 10.1080/23723556.2020.1868266 |
0.314 |
|
2021 |
Petroni G, Kroemer G, Galluzzi L. Immunogenic Therapies Drive CAR T Cells towards Superior Efficacy. Trends in Cancer. PMID 33518493 DOI: 10.1016/j.trecan.2021.01.005 |
0.382 |
|
2020 |
Petroni G, Buqué A, Zitvogel L, Kroemer G, Galluzzi L. Immunomodulation by targeted anticancer agents. Cancer Cell. PMID 33338426 DOI: 10.1016/j.ccell.2020.11.009 |
0.345 |
|
2020 |
Yamazaki T, Pedro JMB, Galluzzi L, Kroemer G, Pietrocola F. Autophagy in the cancer-immunity dialogue. Advanced Drug Delivery Reviews. PMID 33301821 DOI: 10.1016/j.addr.2020.12.003 |
0.727 |
|
2020 |
Fucikova J, Kepp O, Kasikova L, Petroni G, Yamazaki T, Liu P, Zhao L, Spisek R, Kroemer G, Galluzzi L. Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death & Disease. 11: 1013. PMID 33243969 DOI: 10.1038/s41419-020-03221-2 |
0.524 |
|
2020 |
Buqué A, Bloy N, Perez-Lanzón M, Iribarren K, Humeau J, Pol JG, Levesque S, Mondragon L, Yamazaki T, Sato A, Aranda F, Durand S, Boissonnas A, Fucikova J, Senovilla L, ... ... Galluzzi L, et al. Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature Communications. 11: 4787. PMID 32943636 DOI: 10.1038/S41467-020-18719-8 |
0.37 |
|
2020 |
Frega G, Wu Q, Le Naour J, Vacchelli E, Galluzzi L, Kroemer G, Kepp O. Trial Watch: experimental TLR7/TLR8 agonists for oncological indications. Oncoimmunology. 9: 1796002. PMID 32934889 DOI: 10.1080/2162402X.2020.1796002 |
0.688 |
|
2020 |
Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 9: 1777625. PMID 32934882 DOI: 10.1080/2162402X.2020.1777625 |
0.701 |
|
2020 |
Le Naour J, Zitvogel L, Galluzzi L, Vacchelli E, Kroemer G. Trial watch: STING agonists in cancer therapy. Oncoimmunology. 9: 1777624. PMID 32934881 DOI: 10.1080/2162402X.2020.1777624 |
0.697 |
|
2020 |
Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E. Trial watch: TLR3 agonists in cancer therapy. Oncoimmunology. 9: 1771143. PMID 32934877 DOI: 10.1080/2162402X.2020.1771143 |
0.689 |
|
2020 |
Buque A, Bloy N, Petroni G, Kroemer G, Galluzzi L. NK cells beat T cells at early breast cancer control. Oncoimmunology. 9: 1806010. PMID 32923169 DOI: 10.1080/2162402X.2020.1806010 |
0.477 |
|
2020 |
Petroni G, Vitale I, Galluzzi L. Caspase 2 and p53 Reunited in Tumor Control. Trends in Cell Biology. PMID 32921524 DOI: 10.1016/J.Tcb.2020.09.001 |
0.443 |
|
2020 |
Hensler M, Kasikova L, Fiser K, Rakova J, Skapa P, Laco J, Lanickova T, Pecen L, Truxova I, Vosahlikova S, Moserova I, Praznovec I, Drochytek V, Rehackova M, Brtnicky T, ... ... Galluzzi L, et al. M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer. Journal For Immunotherapy of Cancer. 8. PMID 32819974 DOI: 10.1136/Jitc-2020-000979 |
0.309 |
|
2020 |
Galluzzi L, Humeau J, Buqué A, Zitvogel L, Kroemer G. Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nature Reviews. Clinical Oncology. PMID 32760014 DOI: 10.1038/S41571-020-0413-Z |
0.534 |
|
2020 |
Yamazaki T, Kirchmair A, Sato A, Buqué A, Rybstein M, Petroni G, Bloy N, Finotello F, Stafford L, Navarro Manzano E, Ayala de la Peña F, García-Martínez E, Formenti SC, Trajanoski Z, Galluzzi L. Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy. Nature Immunology. PMID 32747819 DOI: 10.1038/S41590-020-0751-0 |
0.431 |
|
2020 |
Fucikova J, Spisek R, Kroemer G, Galluzzi L. Calreticulin and cancer. Cell Research. PMID 32733014 DOI: 10.1038/S41422-020-0383-9 |
0.547 |
|
2020 |
Buqué A, Bloy N, Perez-Lanzón M, Iribarren K, Humeau J, Pol JG, Levesque S, Mondragon L, Yamazaki T, Sato A, Aranda F, Durand S, Boissonnas A, Fucikova J, Senovilla L, ... ... Galluzzi L, et al. Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature Communications. 11: 3819. PMID 32732875 DOI: 10.1038/S41467-020-17644-0 |
0.471 |
|
2020 |
Buqué A, Bloy N, Kroemer G, Galluzzi L. Potential mechanisms of cancer prevention by nicotinamide. British Journal of Pharmacology. PMID 32383227 DOI: 10.1111/Bph.15096 |
0.439 |
|
2020 |
Petroni G, Galluzzi L. Cancer Immunotherapy with CDK7 Inhibitors. Trends in Cancer. 6: 361-363. PMID 32348731 DOI: 10.1016/J.Trecan.2020.02.005 |
0.429 |
|
2020 |
Petroni G, Formenti SC, Chen-Kiang S, Galluzzi L. Immunomodulation by anticancer cell cycle inhibitors. Nature Reviews. Immunology. PMID 32346095 DOI: 10.1038/S41577-020-0300-Y |
0.469 |
|
2020 |
Chong SJF, Marchi S, Petroni G, Kroemer G, Galluzzi L, Pervaiz S. Noncanonical Cell Fate Regulation by Bcl-2 Proteins. Trends in Cell Biology. PMID 32307222 DOI: 10.1016/J.Tcb.2020.03.004 |
0.524 |
|
2020 |
Galluzzi L, Kroemer G. Transient Autophagy Inhibition Precipitates Oncogenesis: A Red Flag For Pharmacological Autophagy Inhibitors? Trends in Cell Biology. 30: 339-340. PMID 32302546 DOI: 10.1016/J.Tcb.2020.02.004 |
0.5 |
|
2020 |
Galluzzi L, Petroni G, Kroemer G. Immunogenicity of cell death driven by immune effectors. Journal For Immunotherapy of Cancer. 8. PMID 32253221 DOI: 10.1136/Jitc-2020-000802 |
0.521 |
|
2020 |
Yamazaki T, Vanpouille-Box C, Demaria S, Galluzzi L. Immunogenic Cell Death Driven by Radiation-Impact on the Tumor Microenvironment. Cancer Treatment and Research. 180: 281-296. PMID 32215874 DOI: 10.1007/978-3-030-38862-1_10 |
0.482 |
|
2020 |
Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, Coukos G, Demaria S, Deutsch E, Draganov D, Edelson RL, Formenti SC, Fucikova J, Gabriele L, et al. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. Journal For Immunotherapy of Cancer. 8. PMID 32209603 DOI: 10.1136/Jitc-2019-000337 |
0.78 |
|
2020 |
Rodriguez-Ruiz ME, Yamazaki T, Buqué A, Bloy N, Silva VAO, Stafford L, Sato A, Galluzzi L. Monitoring abscopal responses to radiation in mice. Methods in Enzymology. 635: 111-125. PMID 32122540 DOI: 10.1016/Bs.Mie.2019.04.014 |
0.368 |
|
2020 |
Yamazaki T, Buqué A, Ames TD, Galluzzi L. PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models. Oncoimmunology. 9: 1721810. PMID 32117585 DOI: 10.1080/2162402X.2020.1721810 |
0.443 |
|
2020 |
Vanmeerbeek I, Sprooten J, De Ruysscher D, Tejpar S, Vandenberghe P, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L, Garg AD. Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. Oncoimmunology. 9: 1703449. PMID 32002302 DOI: 10.1080/2162402X.2019.1703449 |
0.567 |
|
2020 |
Fucikova J, Kline JP, Galluzzi L, Spisek R. Calreticulin arms NK cells against leukemia. Oncoimmunology. 9: 1671763. PMID 32002282 DOI: 10.1080/2162402X.2019.1671763 |
0.438 |
|
2020 |
Hazari Y, Bravo-San Pedro JM, Hetz C, Galluzzi L, Kroemer G. Autophagy in hepatic adaptation to stress. Journal of Hepatology. 72: 183-196. PMID 31849347 DOI: 10.1016/J.Jhep.2019.08.026 |
0.459 |
|
2020 |
Yamazaki T, Buqué A, Rybstein M, Chen J, Sato A, Galluzzi L. Correction to: Methods to Detect Immunogenic Cell Death In Vivo. Methods in Molecular Biology (Clifton, N.J.). 2055: C1. PMID 31701467 DOI: 10.1007/978-1-4939-9773-2_32 |
0.349 |
|
2020 |
Yamazaki T, Martinez AB, Rybstein M, Chen J, Sato A, Galluzzi L. Methods to Detect Immunogenic Cell Death In Vivo. Methods in Molecular Biology (Clifton, N.J.). 2055: 433-452. PMID 31502164 DOI: 10.1007/978-1-4939-9773-2_20 |
0.503 |
|
2020 |
Truxova I, Kasikova L, Salek C, Hensler M, Lysak D, Holicek P, Bilkova P, Holubova M, Chen X, Mikyskova R, Reinis M, Kovar M, Tomalova B, Kline J, Galluzzi L, et al. Abstract B96: Calreticulin exposure on malignant blasts correlates with improved NK cell-mediated cytotoxicity in AML patients Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm19-B96 |
0.438 |
|
2019 |
Rodriguez-Ruiz ME, Vitale I, Harrington KJ, Melero I, Galluzzi L. Immunological impact of cell death signaling driven by radiation on the tumor microenvironment. Nature Immunology. PMID 31873291 DOI: 10.1038/S41590-019-0561-4 |
0.465 |
|
2019 |
Galluzzi L. Targeting Mutant KRAS for Immunogenic Cell Death Induction. Trends in Pharmacological Sciences. PMID 31818506 DOI: 10.1016/j.tips.2019.11.004 |
0.337 |
|
2019 |
Lhuillier C, Galluzzi L. Preface-Dendritic cells: Master regulators of innate and adaptive immunity. International Review of Cell and Molecular Biology. 348: ix-xiv. PMID 31810557 DOI: 10.1016/S1937-6448(19)30095-4 |
0.358 |
|
2019 |
Bravo-San Pedro JM, Sica V, Martins I, Pol J, Loos F, Maiuri MC, Durand S, Bossut N, Aprahamian F, Anagnostopoulos G, Niso-Santano M, Aranda F, Ramírez-Pardo I, Lallement J, Denom J, ... ... Galluzzi L, et al. Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity. Cell Metabolism. 30: 1171. PMID 31801056 DOI: 10.1016/j.cmet.2019.10.011 |
0.532 |
|
2019 |
Kasikova L, Hensler M, Truxova I, Skapa P, Laco J, Belicova L, Praznovec I, Vosahlikova S, Halaska MJ, Brtnicky T, Rob L, Presl J, Kostun J, Cremer I, Ryska A, ... ... Galluzzi L, et al. Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients. Journal For Immunotherapy of Cancer. 7: 312. PMID 31747968 DOI: 10.1186/S40425-019-0781-Z |
0.5 |
|
2019 |
Rodriguez-Ruiz ME, Buqué A, Hensler M, Chen J, Bloy N, Petroni G, Sato A, Yamazaki T, Fucikova J, Galluzzi L. Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients. Oncoimmunology. 8: e1655964. PMID 31646105 DOI: 10.1080/2162402X.2019.1655964 |
0.445 |
|
2019 |
Buqué A, Rodriguez-Ruiz ME, Fucikova J, Galluzzi L. Apoptotic caspases cut down the immunogenicity of radiation. Oncoimmunology. 8: e1655364. PMID 31646103 DOI: 10.1080/2162402X.2019.1655364 |
0.352 |
|
2019 |
Sprooten J, Ceusters J, Coosemans A, Agostinis P, De Vleeschouwer S, Zitvogel L, Kroemer G, Galluzzi L, Garg AD. Trial watch: dendritic cell vaccination for cancer immunotherapy. Oncoimmunology. 8: e1638212. PMID 31646087 DOI: 10.1080/2162402X.2019.1638212 |
0.42 |
|
2019 |
Truxova I, Kasikova L, Salek C, Hensler M, Lysak D, Holicek P, Bilkova P, Holubova M, Chen X, Mikyskova R, Reinis M, Kovar M, Tomalova B, Kline JP, Galluzzi L, et al. Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients. Haematologica. PMID 31582537 DOI: 10.3324/Haematol.2019.223933 |
0.426 |
|
2019 |
Buque A, Galluzzi L, Casares N. Today's special on the anticancer menu: immunomodulation by antifolates. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31562205 DOI: 10.1158/1078-0432.Ccr-19-2775 |
0.384 |
|
2019 |
Montrose DC, Galluzzi L. Drugging cancer metabolism: Expectations vs. reality. International Review of Cell and Molecular Biology. 347: 1-26. PMID 31451211 DOI: 10.1016/Bs.Ircmb.2019.07.007 |
0.372 |
|
2019 |
Bravo-San Pedro JM, Sica V, Martins I, Pol J, Loos F, Maiuri MC, Durand S, Bossut N, Aprahamian F, Anagnostopoulos G, Niso-Santano M, Aranda F, Ramírez-Pardo I, Lallement J, Denom J, ... ... Galluzzi L, et al. Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity. Cell Metabolism. PMID 31422903 DOI: 10.1016/J.Cmet.2019.07.010 |
0.636 |
|
2019 |
Ko EC, Galluzzi L. Radiation unlocks the therapeutic potential of immune checkpoint blockers in lung cancer patients. Oncoimmunology. 8: 1606624. PMID 31413913 DOI: 10.1080/2162402X.2019.1606624 |
0.344 |
|
2019 |
Tatsuno K, Yamazaki T, Hanlon D, Han P, Robinson E, Sobolev O, Yurter A, Rivera-Molina F, Arshad N, Edelson RL, Galluzzi L. Extracorporeal photochemotherapy induces bona fide immunogenic cell death. Cell Death & Disease. 10: 578. PMID 31371700 DOI: 10.1038/S41419-019-1819-3 |
0.475 |
|
2019 |
Deutsch E, Chargari C, Galluzzi L, Kroemer G. Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy. The Lancet. Oncology. 20: e452-e463. PMID 31364597 DOI: 10.1016/S1470-2045(19)30171-8 |
0.425 |
|
2019 |
Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and Metabolism in the Tumor Microenvironment. Cell Metabolism. 30: 36-50. PMID 31269428 DOI: 10.1016/J.Cmet.2019.06.001 |
0.473 |
|
2019 |
Galluzzi L, Green DR. Autophagy-Independent Functions of the Autophagy Machinery. Cell. 177: 1682-1699. PMID 31199916 DOI: 10.1016/J.Cell.2019.05.026 |
0.356 |
|
2019 |
Lévesque S, Pol JG, Ferrere G, Galluzzi L, Zitvogel L, Kroemer G. Trial watch: dietary interventions for cancer therapy. Oncoimmunology. 8: 1591878. PMID 31143510 DOI: 10.1080/2162402X.2019.1591878 |
0.452 |
|
2019 |
Bedognetti D, Ceccarelli M, Galluzzi L, Lu R, Palucka K, Samayoa J, Spranger S, Warren S, Wong KK, Ziv E, Chowell D, Coussens LM, De Carvalho DD, DeNardo DG, Galon J, et al. Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop. Journal For Immunotherapy of Cancer. 7: 131. PMID 31113486 DOI: 10.1186/S40425-019-0602-4 |
0.416 |
|
2019 |
Fucikova J, Rakova J, Hensler M, Kasikova L, Belicová L, Hladikova K, Truxova I, Skapa P, Laco J, Pecen L, Praznovec I, Halaska MJ, Brtnicky T, Kodet R, Fialová A, ... ... Galluzzi L, et al. TIM-3 dictates functional orientation of the immune infiltrate in ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31076549 DOI: 10.1158/1078-0432.Ccr-18-4175 |
0.348 |
|
2019 |
Stoll G, Kremer M, Bloy N, Joseph A, Castedo M, Meurice G, Klein C, Galluzzi L, Michels J, Kroemer G. Metabolic enzymes expressed by cancer cells impact the immune infiltrate. Oncoimmunology. 8: e1571389. PMID 31069148 DOI: 10.1080/2162402X.2019.1571389 |
0.74 |
|
2019 |
Vitale I, Manic G, Galassi C, Galluzzi L. Stress responses in stromal cells and tumor homeostasis. Pharmacology & Therapeutics. PMID 30998941 DOI: 10.1016/J.Pharmthera.2019.04.004 |
0.44 |
|
2019 |
Sica V, Bravo-San Pedro JM, Izzo V, Pol J, Pierredon S, Enot D, Durand S, Bossut N, Chery A, Souquere S, Pierron G, Vartholomaiou E, Zamzami N, Soussi T, Sauvat A, ... ... Galluzzi L, et al. Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate. Cell Reports. 27: 820-834.e9. PMID 30995479 DOI: 10.1016/J.Celrep.2019.03.058 |
0.796 |
|
2019 |
Galluzzi L, Kroemer G. Cancer Cells Thrive on Stress. Trends in Cell Biology. PMID 30962044 DOI: 10.1016/J.Tcb.2019.03.005 |
0.476 |
|
2019 |
Galluzzi L, Kroemer G. Cancer Cells Thrive on Stress. Trends in Cell Biology. 29: 449-451. PMID 30962043 DOI: 10.1016/j.tcb.2019.03.002 |
0.392 |
|
2019 |
Wennerberg E, Galluzzi L. Born to Kill: NK Cells Go to War against Cancer. Trends in Cancer. 5: 143-145. PMID 30898260 DOI: 10.1016/J.Trecan.2018.12.005 |
0.446 |
|
2019 |
Galluzzi L, Kroemer G. Etiological involvement of CFTR in apparently unrelated human diseases. Molecular & Cellular Oncology. 6: 1558874. PMID 30788425 DOI: 10.1080/23723556.2018.1558874 |
0.349 |
|
2019 |
Vitale I, Sistigu A, Manic G, Rudqvist NP, Trajanoski Z, Galluzzi L. Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy. Trends in Cell Biology. PMID 30765144 DOI: 10.1016/J.Tcb.2019.01.003 |
0.374 |
|
2019 |
Pabla S, Conroy JM, Nesline MK, Glenn ST, Papanicolau-Sengos A, Burgher B, Hagen J, Giamo V, Andreas J, Lenzo FL, Yirong W, Dy GK, Yau E, Early A, Chen H, ... ... Galluzzi L, et al. Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients. Journal For Immunotherapy of Cancer. 7: 27. PMID 30709424 DOI: 10.1186/S40425-019-0506-3 |
0.342 |
|
2019 |
Rudqvist NP, Galluzzi L. T Cells: Friends and Foes. International Review of Cell and Molecular Biology. 342: xi-xiv. PMID 30635096 DOI: 10.1016/S1937-6448(19)30009-7 |
0.306 |
|
2019 |
Kroemer G, Zitvogel L, Galluzzi L. Victories and deceptions in tumor immunology: Stimuvax Oncoimmunology. 2: e23687. PMID 23483762 DOI: 10.4161/Onci.23687 |
0.52 |
|
2019 |
Liberto MD, Hu Y, Huang X, Lee CY, Wang K, Bartlett NL, Ridling L, Blum KA, Maddocks KJ, Park SI, Ruan J, Eng K, Galluzzi L, Leonard JP, Martin P, et al. Composite Copy Number Variation in CDK4 , CDKN2A and RB1 Predisposes Mantle Cell Lymphoma to Expansion of PD1+ Tumor Cells and Resistance to CDK4/6 Inhibitor Therapy as Revealed by Integrative Longitudinal scRNA-seq Blood. 134: 1492-1492. DOI: 10.1182/Blood-2019-130944 |
0.356 |
|
2019 |
Lee CY, Liberto MD, Hu Y, Huang X, Bartlett NL, Maddocks KJ, Leonard JP, Rudqvist N, Galluzzi L, Martin P, Elemento O, Chen-Kiang S. T-Cell Clonal Expansion and Activation Associated with Durable Clinical Response to Dual BTK and CDK4/6 Inhibitor Therapy in Mantle Cell Lymphoma Blood. 134: 3973-3973. DOI: 10.1182/Blood-2019-122322 |
0.398 |
|
2019 |
Yamazaki T, Ames TD, Galluzzi L. Abstract B199: Potent induction of immunogenic cell death by PT-112 Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B199 |
0.443 |
|
2019 |
Rybstein M, Yamazaki T, Martinez AB, Galluzzi L. Abstract A150: Enhancing abscopal responses to radiation therapy by manipulating autophagy Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-A150 |
0.491 |
|
2018 |
Truxova I, Kasikova L, Hensler M, Skapa P, Laco J, Pecen L, Belicova L, Praznovec I, Halaska MJ, Brtnicky T, Salkova E, Rob L, Kodet R, Goc J, Sautes-Fridman C, ... ... Galluzzi L, et al. Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients. Journal For Immunotherapy of Cancer. 6: 139. PMID 30526667 DOI: 10.1186/S40425-018-0446-3 |
0.395 |
|
2018 |
Galluzzi L, Kroemer G. Potent immunosuppressive effects of the oncometabolite -2-hydroxyglutarate. Oncoimmunology. 7: e1528815. PMID 30524910 DOI: 10.1080/2162402X.2018.1528815 |
0.548 |
|
2018 |
Smith M, García-Martínez E, Pitter MR, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Toll-like receptor agonists in cancer immunotherapy. Oncoimmunology. 7: e1526250. PMID 30524908 DOI: 10.1080/2162402X.2018.1526250 |
0.439 |
|
2018 |
Bezu L, Kepp O, Cerrato G, Pol J, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Peptide-based vaccines in anticancer therapy. Oncoimmunology. 7: e1511506. PMID 30524907 DOI: 10.1080/2162402X.2018.1511506 |
0.436 |
|
2018 |
G Pol J, Lévesque S, Workenhe ST, Gujar S, Le Boeuf F, R Clements D, Fahrner JE, Fend L, C Bell J, L Mossman K, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. Oncoimmunology. 7: e1503032. PMID 30524901 DOI: 10.1080/2162402X.2018.1503032 |
0.479 |
|
2018 |
Marchi S, Corricelli M, Branchini A, Vitto VAM, Missiroli S, Morciano G, Perrone M, Ferrarese M, Giorgi C, Pinotti M, Galluzzi L, Kroemer G, Pinton P. Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca levels and tumor growth. The Embo Journal. PMID 30504268 DOI: 10.15252/Embj.201899435 |
0.444 |
|
2018 |
Galluzzi L, Yamazaki T, Kroemer G. Linking cellular stress responses to systemic homeostasis. Nature Reviews. Molecular Cell Biology. PMID 30305710 DOI: 10.1038/S41580-018-0068-0 |
0.496 |
|
2018 |
Galluzzi L, Chan TA, Kroemer G, Wolchok JD, López-Soto A. The hallmarks of successful anticancer immunotherapy. Science Translational Medicine. 10. PMID 30232229 DOI: 10.1126/Scitranslmed.Aat7807 |
0.497 |
|
2018 |
Galluzzi L, Spranger S, Fuchs E, López-Soto A. WNT Signaling in Cancer Immunosurveillance. Trends in Cell Biology. PMID 30220580 DOI: 10.1016/J.Tcb.2018.08.005 |
0.354 |
|
2018 |
Vanpouille-Box C, Demaria S, Formenti SC, Galluzzi L. Cytosolic DNA Sensing in Organismal Tumor Control. Cancer Cell. 34: 361-378. PMID 30216189 DOI: 10.1016/J.Ccell.2018.05.013 |
0.373 |
|
2018 |
Bonora M, Wieckowski MR, Sinclair DA, Kroemer G, Pinton P, Galluzzi L. Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles. Nature Reviews. Cardiology. PMID 30177752 DOI: 10.1038/S41569-018-0074-0 |
0.421 |
|
2018 |
Buqué A, Galluzzi L. Modeling Tumor Immunology and Immunotherapy in Mice. Trends in Cancer. 4: 599-601. PMID 30149876 DOI: 10.1016/J.Trecan.2018.07.003 |
0.398 |
|
2018 |
García-Martínez E, Smith M, Buqué A, Aranda F, de la Peña FA, Ivars A, Cánovas MS, Conesa MAV, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. Oncoimmunology. 7: e1433982. PMID 29872569 DOI: 10.1080/2162402X.2018.1433982 |
0.462 |
|
2018 |
Galluzzi L, Vanpouille-Box C, Bakhoum SF, Demaria S. SnapShot: CGAS-STING Signaling. Cell. 173: 276-276.e1. PMID 29570996 DOI: 10.1016/J.Cell.2018.03.015 |
0.311 |
|
2018 |
Galluzzi L, Vanpouille-Box C. BAX and BAK at the Gates of Innate Immunity. Trends in Cell Biology. PMID 29555208 DOI: 10.1016/J.Tcb.2018.02.010 |
0.404 |
|
2018 |
Rybstein MD, Bravo-San Pedro JM, Kroemer G, Galluzzi L. The autophagic network and cancer. Nature Cell Biology. 20: 243-251. PMID 29476153 DOI: 10.1038/S41556-018-0042-2 |
0.469 |
|
2018 |
Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death and Differentiation. PMID 29362479 DOI: 10.1038/S41418-017-0012-4 |
0.541 |
|
2018 |
Carmona-Gutierrez D, Bauer MA, Zimmermann A, Aguilera A, Austriaco N, Ayscough K, Balzan R, Bar-Nun S, Barrientos A, Belenky P, Blondel M, Braun RJ, Breitenbach M, Burhans WC, Büttner S, ... ... Galluzzi L, et al. Guidelines and recommendations on yeast cell death nomenclature. Microbial Cell (Graz, Austria). 5: 4-31. PMID 29354647 DOI: 10.15698/Mic2018.01.607 |
0.514 |
|
2017 |
Kroemer G, Galluzzi L. Lysosome-targeting agents in cancer therapy. Oncotarget. 8: 112168-112169. PMID 29348815 DOI: 10.18632/Oncotarget.21451 |
0.47 |
|
2017 |
Lhuillier C, Vanpouille-Box C, Galluzzi L, Formenti SC, Demaria S. Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers. Seminars in Cancer Biology. PMID 29258856 DOI: 10.1016/J.Semcancer.2017.12.007 |
0.346 |
|
2017 |
Chen JJ, Galluzzi L. Fighting Resilient Cancers with Iron. Trends in Cell Biology. PMID 29223642 DOI: 10.1016/J.Tcb.2017.11.007 |
0.366 |
|
2017 |
Porporato PE, Filigheddu N, Bravo-San Pedro JM, Kroemer G, Galluzzi L. Mitochondrial metabolism and cancer. Cell Research. PMID 29219147 DOI: 10.1038/Cr.2017.155 |
0.542 |
|
2017 |
Pierini S, Perales-Linares R, Uribe-Herranz M, Pol JG, Zitvogel L, Kroemer G, Facciabene A, Galluzzi L. Trial watch: DNA-based vaccines for oncological indications. Oncoimmunology. 6: e1398878. PMID 29209575 DOI: 10.1080/2162402X.2017.1398878 |
0.407 |
|
2017 |
Garg AD, More S, Rufo N, Mece O, Sassano ML, Agostinis P, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics. Oncoimmunology. 6: e1386829. PMID 29209573 DOI: 10.1080/2162402X.2017.1386829 |
0.578 |
|
2017 |
Cabo M, Offringa R, Zitvogel L, Kroemer G, Muntasell A, Galluzzi L. Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications. Oncoimmunology. 6: e1371896. PMID 29209572 DOI: 10.1080/2162402X.2017.1371896 |
0.424 |
|
2017 |
Vanpouille-Box C, Lhuillier C, Bezu L, Aranda F, Yamazaki T, Kepp O, Fucikova J, Spisek R, Demaria S, Formenti SC, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immune checkpoint blockers for cancer therapy. Oncoimmunology. 6: e1373237. PMID 29147629 DOI: 10.1080/2162402X.2017.1373237 |
0.5 |
|
2017 |
Fournier C, Martin F, Zitvogel L, Kroemer G, Galluzzi L, Apetoh L. Trial Watch: Adoptively transferred cells for anticancer immunotherapy. Oncoimmunology. 6: e1363139. PMID 29147628 DOI: 10.1080/2162402X.2017.1363139 |
0.53 |
|
2017 |
Vanpouille-Box C, Galluzzi L. CD103(+) cells at the forefront of anticancer immunity. Oncoimmunology. 6: e1356154. PMID 29147613 DOI: 10.1080/2162402X.2017.1356154 |
0.321 |
|
2017 |
Conroy JM, Pabla S, Glenn ST, Burgher B, Nesline M, Papanicolau-Sengos A, Andreas J, Giamo V, Lenzo FL, Hyland FCL, Omilian A, Bshara W, Qin M, He J, Puzanov I, ... ... Galluzzi L, et al. Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors. The Journal of Molecular Diagnostics : Jmd. PMID 29061374 DOI: 10.1016/J.Jmoldx.2017.10.001 |
0.316 |
|
2017 |
Wennerberg E, Vanpouille-Box C, Bornstein S, Yamazaki T, Demaria S, Galluzzi L. Immune recognition of irradiated cancer cells. Immunological Reviews. 280: 220-230. PMID 29027232 DOI: 10.1111/Imr.12568 |
0.477 |
|
2017 |
Bantug GR, Galluzzi L, Kroemer G, Hess C. The spectrum of T cell metabolism in health and disease. Nature Reviews. Immunology. PMID 28944771 DOI: 10.1038/Nri.2017.99 |
0.451 |
|
2017 |
Garg AD, Vara Perez M, Schaaf M, Agostinis P, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Dendritic cell-based anticancer immunotherapy. Oncoimmunology. 6: e1328341. PMID 28811970 DOI: 10.1080/2162402X.2017.1328341 |
0.469 |
|
2017 |
López-Soto A, Gonzalez S, Smyth MJ, Galluzzi L. Control of Metastasis by NK Cells. Cancer Cell. 32: 135-154. PMID 28810142 DOI: 10.1016/J.Ccell.2017.06.009 |
0.44 |
|
2017 |
Galluzzi L, Kroemer G. Secondary Necrosis: Accidental No More. Trends in Cancer. 3: 1-2. PMID 28718422 DOI: 10.1016/J.Trecan.2016.12.001 |
0.513 |
|
2017 |
Galluzzi L, Kroemer G. Novel immune checkpoint blocker to treat Merkel cell carcinoma. Oncoimmunology. 6: e1315496. PMID 28680746 DOI: 10.1080/2162402X.2017.1315496 |
0.47 |
|
2017 |
Galluzzi L, Kroemer G. An epigenetic modifier triggers therapeutic immune responses against breast cancer. Oncoimmunology. 6: e1313376. PMID 28638742 DOI: 10.1080/2162402X.2017.1313376 |
0.436 |
|
2017 |
Yamazaki T, Galluzzi L. TREX1 Cuts Down on Cancer Immunogenicity. Trends in Cell Biology. PMID 28625463 DOI: 10.1016/J.Tcb.2017.06.001 |
0.358 |
|
2017 |
Galluzzi L, Yamazaki T, Demaria S. Heavy Metal to Rock the Immune Infiltrate. Trends in Immunology. PMID 28602618 DOI: 10.1016/J.It.2017.05.007 |
0.361 |
|
2017 |
Pietrocola F, Bravo-San Pedro JM, Galluzzi L, Kroemer G. Autophagy in natural and therapy-driven anticancer immunosurveillance. Autophagy. 0. PMID 28598229 DOI: 10.1080/15548627.2017.1310356 |
0.757 |
|
2017 |
Galluzzi L, Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cecconi F, Choi AM, Chu CT, Codogno P, Colombo MI, Cuervo AM, Debnath J, Deretic V, Dikic I, Eskelinen EL, et al. Molecular definitions of autophagy and related processes. The Embo Journal. PMID 28596378 DOI: 10.15252/Embj.201796697 |
0.443 |
|
2017 |
Bonora M, Morganti C, Morciano G, Pedriali G, Lebiedzinska-Arciszewska M, Aquila G, Giorgi C, Rizzo P, Campo G, Ferrari R, Kroemer G, Wieckowski MR, Galluzzi L, Pinton P. Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation. Embo Reports. PMID 28566520 DOI: 10.15252/Embr.201643602 |
0.393 |
|
2017 |
Bravo-San Pedro JM, Kroemer G, Galluzzi L. Autophagy and Mitophagy in Cardiovascular Disease. Circulation Research. 120: 1812-1824. PMID 28546358 DOI: 10.1161/Circresaha.117.311082 |
0.463 |
|
2017 |
Galluzzi L, Bravo-San Pedro JM, Levine B, Green DR, Kroemer G. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nature Reviews. Drug Discovery. PMID 28529316 DOI: 10.1038/Nrd.2017.22 |
0.472 |
|
2017 |
Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Reply: Immunosuppressive cell death in cancer. Nature Reviews. Immunology. PMID 28480896 DOI: 10.1038/Nri.2017.48 |
0.525 |
|
2017 |
Vitale I, Manic G, De Maria R, Kroemer G, Galluzzi L. DNA Damage in Stem Cells. Molecular Cell. 66: 306-319. PMID 28475867 DOI: 10.1016/J.Molcel.2017.04.006 |
0.482 |
|
2017 |
Galluzzi L, Kroemer G. Calreticulin and type I interferon: An unsuspected connection. Oncoimmunology. 6: e1288334. PMID 28405522 DOI: 10.1080/2162402X.2017.1288334 |
0.334 |
|
2017 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. [Autophagy, fitness and longevity]. Medecine Sciences : M/S. 33: 246-251. PMID 28367810 DOI: 10.1051/Medsci/20173303010 |
0.454 |
|
2017 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. Mitophagy: Permitted by Prohibitin. Current Biology : Cb. 27: R73-R76. PMID 28118594 DOI: 10.1016/J.Cub.2016.11.055 |
0.413 |
|
2017 |
López-Soto A, Bravo-San Pedro JM, Kroemer G, Galluzzi L, Gonzalez S. Involvement of autophagy in NK cell development and function. Autophagy. 0. PMID 28103115 DOI: 10.1080/15548627.2016.1274486 |
0.561 |
|
2017 |
Gandhi S, Pabla S, Nesline M, Pandey M, Ernstoff MS, Dy GK, Conroy JM, Glenn S, Burgher B, Qin M, Andreas J, Giamo V, Papanicolau-Sengos A, Galluzzi L, He J, et al. Algorithmic prediction of response to checkpoint inhibitors: Hyperprogressors versus responders. Journal of Clinical Oncology. 35: 11565-11565. DOI: 10.1200/Jco.2017.35.15_Suppl.11565 |
0.324 |
|
2016 |
Galluzzi L, Kepp O, Kroemer G. Mitochondrial regulation of cell death: a phylogenetically conserved control. Microbial Cell (Graz, Austria). 3: 101-108. PMID 28357340 DOI: 10.15698/Mic2016.03.483 |
0.514 |
|
2016 |
Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Reply: The complement system is also important in immunogenic cell death. Nature Reviews. Immunology. PMID 28028312 DOI: 10.1038/Nri.2016.143 |
0.525 |
|
2016 |
Mondragón L, Kroemer G, Galluzzi L. Immunosuppressive γδ T cells foster pancreatic carcinogenesis. Oncoimmunology. 5: e1237328. PMID 27999755 DOI: 10.1080/2162402X.2016.1237328 |
0.422 |
|
2016 |
Kroemer G, Galluzzi L. Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors. Oncotarget. PMID 27974686 DOI: 10.18632/Oncotarget.13892 |
0.494 |
|
2016 |
Galluzzi L, Kepp O, Chan FK, Kroemer G. Necroptosis: Mechanisms and Relevance to Disease. Annual Review of Pathology. PMID 27959630 DOI: 10.1146/Annurev-Pathol-052016-100247 |
0.488 |
|
2016 |
Paluch BE, Glenn ST, Conroy JM, Papanicolau-Sengos A, Bshara W, Omilian AR, Brese E, Nesline M, Burgher B, Andreas J, Odunsi K, Eng K, He J, Qin M, Gardner M, ... Galluzzi L, et al. Robust detection of immune transcripts in FFPE samples using targeted RNA sequencing. Oncotarget. PMID 27911273 DOI: 10.18632/Oncotarget.13691 |
0.303 |
|
2016 |
Galluzzi L, Pedro JM, Demaria S, Formenti SC, Kroemer G. Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. Nature Reviews. Clinical Oncology. PMID 27845767 DOI: 10.1038/Nrclinonc.2016.183 |
0.554 |
|
2016 |
Galluzzi L, Zitvogel L, Kroemer G. Immunological Mechanisms Underneath the Efficacy of Cancer Therapy. Cancer Immunology Research. 4: 895-902. PMID 27803050 DOI: 10.1158/2326-6066.Cir-16-0197 |
0.496 |
|
2016 |
Fucikova J, Truxova I, Hensler M, Becht E, Kasikova L, Moserova I, Vosahlikova S, Klouckova J, Church SE, Cremer I, Kepp O, Kroemer G, Galluzzi L, Salek C, Spisek R. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients. Blood. PMID 27802968 DOI: 10.1182/Blood-2016-08-731737 |
0.519 |
|
2016 |
Vacchelli E, Bloy N, Aranda F, Buqué A, Cremer I, Demaria S, Eggermont A, Formenti SC, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, ... Galluzzi L, et al. Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology. 5: e1214790. PMID 27757313 DOI: 10.1080/2162402X.2016.1214790 |
0.7 |
|
2016 |
Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease. Nature Reviews. Immunology. PMID 27748397 DOI: 10.1038/Nri.2016.107 |
0.576 |
|
2016 |
Galluzzi L. Novel Insights into PML-Dependent Oncosuppression. Trends in Cell Biology. 26: 889-890. PMID 27663133 DOI: 10.1016/J.Tcb.2016.09.001 |
0.387 |
|
2016 |
Galluzzi L, Kroemer G. Aberrant ketolysis fuels hepatocellular cancer progression. Cell Research. 26: 1077-1078. PMID 27644988 DOI: 10.1038/Cr.2016.110 |
0.477 |
|
2016 |
López-Otín C, Galluzzi L, Freije JM, Madeo F, Kroemer G. Metabolic Control of Longevity. Cell. 166: 802-21. PMID 27518560 DOI: 10.1016/J.Cell.2016.07.031 |
0.361 |
|
2016 |
Buqué A, Bloy N, Aranda F, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy. Oncoimmunology. 5: e1149674. PMID 27471617 DOI: 10.1080/2162402X.2016.1149674 |
0.54 |
|
2016 |
Kroemer G, Galluzzi L, Zitvogel L. STAT3 inhibition for cancer therapy: Cell-autonomous effects only? Oncoimmunology. 5: e1126063. PMID 27467938 DOI: 10.1080/2162402X.2015.1126063 |
0.584 |
|
2016 |
Galluzzi L, Buqué A, Kroemer G. Prevention of breast cancer by RANKL/RANK blockade. Cell Research. 26: 751-2. PMID 27325297 DOI: 10.1038/Cr.2016.79 |
0.395 |
|
2016 |
Galluzzi L, Bravo-San Pedro JM, Blomgren K, Kroemer G. Autophagy in acute brain injury. Nature Reviews. Neuroscience. 17: 467-84. PMID 27256553 DOI: 10.1038/Nrn.2016.51 |
0.439 |
|
2016 |
Sica V, Manic G, Kroemer G, Vitale I, Galluzzi L. Cytofluorometric Quantification of Cell Death Elicited by NLR Proteins. Methods in Molecular Biology (Clifton, N.J.). 1417: 231-45. PMID 27221495 DOI: 10.1007/978-1-4939-3566-6_17 |
0.674 |
|
2016 |
Galluzzi L, Kroemer G. A four-lane highway to cancer. Nature Reviews. Molecular Cell Biology. 17: 398. PMID 27220642 DOI: 10.1038/Nrm.2016.73 |
0.412 |
|
2016 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. Defective Autophagy Initiates Malignant Transformation. Molecular Cell. 62: 473-4. PMID 27203173 DOI: 10.1016/J.Molcel.2016.05.001 |
0.414 |
|
2016 |
Izzo V, Bravo-San Pedro JM, Sica V, Kroemer G, Galluzzi L. Mitochondrial Permeability Transition: New Findings and Persisting Uncertainties. Trends in Cell Biology. 26: 655-67. PMID 27161573 DOI: 10.1016/J.Tcb.2016.04.006 |
0.66 |
|
2016 |
Iribarren K, Bloy N, Buqué A, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Špíšek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. Oncoimmunology. 5: e1088631. PMID 27141345 DOI: 10.1080/2162402X.2015.1088631 |
0.472 |
|
2016 |
Sica V, Maiuri MC, Kroemer G, Galluzzi L. Detection of Apoptotic Versus Autophagic Cell Death by Flow Cytometry. Methods in Molecular Biology (Clifton, N.J.). 1419: 1-16. PMID 27108427 DOI: 10.1007/978-1-4939-3581-9_1 |
0.713 |
|
2016 |
Galluzzi L, Kroemer G. Amino acid deprivation promotes intestinal homeostasis through autophagy. Oncotarget. 7: 29877-8. PMID 27105494 DOI: 10.18632/Oncotarget.8841 |
0.527 |
|
2016 |
Pol J, Buqué A, Aranda F, Bloy N, Cremer I, Eggermont A, Erbs P, Fucikova J, Galon J, Limacher JM, Preville X, Sautès-Fridman C, Spisek R, Zitvogel L, Kroemer G, ... Galluzzi L, et al. Trial Watch-Oncolytic viruses and cancer therapy. Oncoimmunology. 5: e1117740. PMID 27057469 DOI: 10.1080/2162402X.2015.1117740 |
0.373 |
|
2016 |
Vacchelli E, Aranda F, Bloy N, Buqué A, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch-Immunostimulation with cytokines in cancer therapy. Oncoimmunology. 5: e1115942. PMID 27057468 DOI: 10.1080/2162402X.2015.1115942 |
0.706 |
|
2016 |
Galluzzi L, Bravo-San Pedro JM, Kepp O, Kroemer G. Regulated cell death and adaptive stress responses. Cellular and Molecular Life Sciences : Cmls. 73: 2405-10. PMID 27048813 DOI: 10.1007/S00018-016-2209-Y |
0.531 |
|
2016 |
Pol J, Kroemer G, Galluzzi L. First oncolytic virus approved for melanoma immunotherapy. Oncoimmunology. 5: e1115641. PMID 26942095 DOI: 10.1080/2162402X.2015.1115641 |
0.372 |
|
2016 |
Galluzzi L, Eggermont A, Kroemer G. Doubling the blockade for melanoma immunotherapy. Oncoimmunology. 5: e1106127. PMID 26942094 DOI: 10.1080/2162402X.2015.1106127 |
0.382 |
|
2016 |
Klionsky DJ, Abdelmohsen K, Abe A, Abedin J, Abeliovich H, Arozena AA, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Galluzzi L, ... ... Galluzzi L, et al. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 Autophagy. 12: 443-443. PMID 26902590 DOI: 10.1080/15548627.2016.1147886 |
0.758 |
|
2016 |
Galluzzi L, López-Soto A, Kumar S, Kroemer G. Caspases Connect Cell-Death Signaling to Organismal Homeostasis. Immunity. 44: 221-31. PMID 26885855 DOI: 10.1016/J.Immuni.2016.01.020 |
0.537 |
|
2016 |
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Galluzzi L, ... ... Galluzzi L, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356 |
0.8 |
|
2016 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. Autophagy Mediates Tumor Suppression via Cellular Senescence. Trends in Cell Biology. 26: 1-3. PMID 26612212 DOI: 10.1016/J.Tcb.2015.11.001 |
0.546 |
|
2016 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. Ferroptosis in p53-dependent oncosuppression and organismal homeostasis. Cell Death and Differentiation. 22: 1237-8. PMID 26143748 DOI: 10.1038/Cdd.2015.54 |
0.486 |
|
2016 |
Galluzzi L, López-Soto A, Kumar S, Kroemer G. Caspases Connect Cell-Death Signaling to Organismal Homeostasis Immunity. 44: 221-231. DOI: 10.1016/j.immuni.2016.01.020 |
0.413 |
|
2015 |
Vitale I, Manic G, Senovilla L, Kroemer G, Galluzzi L. Karyotypic Aberrations in Oncogenesis and Cancer Therapy. Trends in Cancer. 1: 124-135. PMID 28741522 DOI: 10.1016/J.Trecan.2015.08.001 |
0.534 |
|
2015 |
Obrist F, Manic G, Kroemer G, Vitale I, Galluzzi L. Trial Watch: Proteasomal inhibitors for anticancer therapy. Molecular & Cellular Oncology. 2: e974463. PMID 27308423 DOI: 10.4161/23723556.2014.974463 |
0.524 |
|
2015 |
Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents. Cancer Cell. 28: 690-714. PMID 26678337 DOI: 10.1016/J.Ccell.2015.10.012 |
0.512 |
|
2015 |
Garg AD, Galluzzi L, Apetoh L, Baert T, Birge RB, Bravo-San Pedro JM, Breckpot K, Brough D, Chaurio R, Cirone M, Coosemans A, Coulie PG, De Ruysscher D, Dini L, de Witte P, et al. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in Immunology. 6: 588. PMID 26635802 DOI: 10.3389/Fimmu.2015.00588 |
0.754 |
|
2015 |
Galluzzi L, Kroemer G. Defective autophagy gets to the brain. Oncotarget. 6: 39396-7. PMID 26575951 DOI: 10.18632/Oncotarget.6318 |
0.522 |
|
2015 |
Galluzzi L, Pietrocola F, Kroemer G. Molecular Regulation of Circadian Rhythms by Polyamines. Cell Metabolism. 22: 757-8. PMID 26536485 DOI: 10.1016/J.Cmet.2015.10.007 |
0.652 |
|
2015 |
Aranda F, Buqué A, Bloy N, Castoldi F, Eggermont A, Cremer I, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Adoptive cell transfer for oncological indications. Oncoimmunology. 4: e1046673. PMID 26451319 DOI: 10.1080/2162402X.2015.1046673 |
0.543 |
|
2015 |
Kroemer G, Senovilla L, Galluzzi L, André F, Zitvogel L. Natural and therapy-induced immunosurveillance in breast cancer. Nature Medicine. 21: 1128-38. PMID 26444637 DOI: 10.1038/Nm.3944 |
0.502 |
|
2015 |
Fucikova J, Moserova I, Urbanova L, Bezu L, Kepp O, Cremer I, Salek C, Strnad P, Kroemer G, Galluzzi L, Spisek R. Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer. Frontiers in Immunology. 6: 402. PMID 26300886 DOI: 10.3389/Fimmu.2015.00402 |
0.55 |
|
2015 |
Sica V, Galluzzi L, Bravo-San Pedro JM, Izzo V, Maiuri MC, Kroemer G. Organelle-Specific Initiation of Autophagy. Molecular Cell. 59: 522-39. PMID 26295960 DOI: 10.1016/J.Molcel.2015.07.021 |
0.67 |
|
2015 |
Kroemer G, Galluzzi L. Immunotherapy of hematological cancers: PD-1 blockade for the treatment of Hodgkin's lymphoma. Oncoimmunology. 4: e1008853. PMID 26155425 DOI: 10.1080/2162402X.2015.1008853 |
0.479 |
|
2015 |
Bloy N, Buqué A, Aranda F, Castoldi F, Eggermont A, Cremer I, Sautès-Fridman C, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Naked and vectored DNA-based anticancer vaccines. Oncoimmunology. 4: e1026531. PMID 26155408 DOI: 10.1080/2162402X.2015.1026531 |
0.45 |
|
2015 |
Kroemer G, Galluzzi L, Zitvogel L, Fridman WH. Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy? Oncoimmunology. 4: e1058597. PMID 26140250 DOI: 10.1080/2162402X.2015.1058597 |
0.429 |
|
2015 |
Kroemer G, Galluzzi L. Combinatorial immunotherapy with checkpoint blockers solves the problem of metastatic melanoma-An exclamation sign with a question mark. Oncoimmunology. 4: e1058037. PMID 26140249 DOI: 10.1080/2162402X.2015.1058037 |
0.432 |
|
2015 |
Pol J, Bloy N, Buqué A, Eggermont A, Cremer I, Sautès-Fridman C, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Peptide-based anticancer vaccines. Oncoimmunology. 4: e974411. PMID 26137405 DOI: 10.4161/2162402X.2014.974411 |
0.365 |
|
2015 |
Pol J, Vacchelli E, Aranda F, Castoldi F, Eggermont A, Cremer I, Sautès-Fridman C, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy. Oncoimmunology. 4: e1008866. PMID 26137404 DOI: 10.1080/2162402X.2015.1008866 |
0.737 |
|
2015 |
Buqué A, Bloy N, Aranda F, Castoldi F, Eggermont A, Cremer I, Fridman WH, Fucikova J, Galon J, Marabelle A, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. Oncoimmunology. 4: e1008814. PMID 26137403 DOI: 10.1080/2162402X.2015.1008814 |
0.489 |
|
2015 |
Enot DP, Niso-Santano M, Durand S, Chery A, Pietrocola F, Vacchelli E, Madeo F, Galluzzi L, Kroemer G. Metabolomic analyses reveal that anti-aging metabolites are depleted by palmitate but increased by oleate in vivo. Cell Cycle (Georgetown, Tex.). 14: 2399-407. PMID 26098646 DOI: 10.1080/15384101.2015.1064206 |
0.757 |
|
2015 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. Necrosis: Linking the Inflammasome to Inflammation. Cell Reports. 11: 1501-2. PMID 26082972 DOI: 10.1016/J.Celrep.2015.05.041 |
0.455 |
|
2015 |
Bezu L, Gomes-da-Silva LC, Dewitte H, Breckpot K, Fucikova J, Spisek R, Galluzzi L, Kepp O, Kroemer G. Corrigendum: "Combinatorial Strategies for the Induction of Immunogenic Cell Death". Frontiers in Immunology. 6: 275. PMID 26082782 DOI: 10.3389/Fimmu.2015.00275 |
0.472 |
|
2015 |
Pietrocola F, Galluzzi L, Bravo-San Pedro JM, Madeo F, Kroemer G. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metabolism. 21: 805-21. PMID 26039447 DOI: 10.1016/J.Cmet.2015.05.014 |
0.658 |
|
2015 |
Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. Type I interferons in anticancer immunity. Nature Reviews. Immunology. 15: 405-14. PMID 26027717 DOI: 10.1038/Nri3845 |
0.46 |
|
2015 |
Bezu L, Gomes-de-Silva LC, Dewitte H, Breckpot K, Fucikova J, Spisek R, Galluzzi L, Kepp O, Kroemer G. Combinatorial strategies for the induction of immunogenic cell death. Frontiers in Immunology. 6: 187. PMID 25964783 DOI: 10.3389/Fimmu.2015.00187 |
0.581 |
|
2015 |
Vacchelli E, Pol J, Bloy N, Eggermont A, Cremer I, Fridman WH, Galon J, Marabelle A, Kohrt H, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Tumor-targeting monoclonal antibodies for oncological indications. Oncoimmunology. 4: e985940. PMID 25949870 DOI: 10.4161/2162402X.2014.985940 |
0.721 |
|
2015 |
Sauvat A, Wang Y, Segura F, Spaggiari S, Müller K, Zhou H, Galluzzi L, Kepp O, Kroemer G. Quantification of cellular viability by automated microscopy and flow cytometry. Oncotarget. 6: 9467-75. PMID 25816366 DOI: 10.18632/Oncotarget.3266 |
0.644 |
|
2015 |
Bonora M, Wieckowsk MR, Chinopoulos C, Kepp O, Kroemer G, Galluzzi L, Pinton P. Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition. Oncogene. 34: 1608. PMID 25790189 DOI: 10.1038/Onc.2014.462 |
0.453 |
|
2015 |
Kroemer G, Bravo-San Pedro JM, Galluzzi L. Novel function of cytoplasmic p53 at the interface between mitochondria and the endoplasmic reticulum. Cell Death & Disease. 6: e1698. PMID 25789973 DOI: 10.1038/Cddis.2015.70 |
0.437 |
|
2015 |
Kepp O, Semeraro M, Bravo-San Pedro JM, Bloy N, Buqué A, Huang X, Zhou H, Senovilla L, Kroemer G, Galluzzi L. eIF2α phosphorylation as a biomarker of immunogenic cell death. Seminars in Cancer Biology. PMID 25749194 DOI: 10.1016/J.Semcancer.2015.02.004 |
0.554 |
|
2015 |
Niso-Santano M, Bravo-San Pedro JM, Maiuri MC, Tavernarakis N, Cecconi F, Madeo F, Codogno P, Galluzzi L, Kroemer G. Novel inducers of BECN1-independent autophagy: cis-unsaturated fatty acids. Autophagy. 11: 575-7. PMID 25714112 DOI: 10.1080/15548627.2015.1017222 |
0.414 |
|
2015 |
Galluzzi L, Pietrocola F, Bravo-San Pedro JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J, Gewirtz DA, Karantza V, Kimmelman A, Kumar S, Levine B, Maiuri MC, Martin SJ, et al. Autophagy in malignant transformation and cancer progression. The Embo Journal. 34: 856-80. PMID 25712477 DOI: 10.15252/Embj.201490784 |
0.743 |
|
2015 |
Zitvogel L, Galluzzi L, Viaud S, Vétizou M, Daillère R, Merad M, Kroemer G. Cancer and the gut microbiota: an unexpected link. Science Translational Medicine. 7: 271ps1. PMID 25609166 DOI: 10.1126/Scitranslmed.3010473 |
0.445 |
|
2015 |
Niso-Santano M, Malik SA, Pietrocola F, Bravo-San Pedro JM, Mariño G, Cianfanelli V, Ben-Younès A, Troncoso R, Markaki M, Sica V, Izzo V, Chaba K, Bauvy C, Dupont N, Kepp O, ... ... Galluzzi L, et al. Unsaturated fatty acids induce non-canonical autophagy. The Embo Journal. 34: 1025-41. PMID 25586377 DOI: 10.15252/Embj.201489363 |
0.822 |
|
2015 |
Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, Alnemri ES, Altucci L, Andrews D, Annicchiarico-Petruzzelli M, Baehrecke EH, Bazan NG, Bertrand MJ, Bianchi K, Blagosklonny MV, et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death and Differentiation. 22: 58-73. PMID 25236395 DOI: 10.1038/Cdd.2014.137 |
0.557 |
|
2014 |
Manic G, Obrist F, Kroemer G, Vitale I, Galluzzi L. Chloroquine and hydroxychloroquine for cancer therapy. Molecular & Cellular Oncology. 1: e29911. PMID 27308318 DOI: 10.4161/Mco.29911 |
0.562 |
|
2014 |
Galluzzi L, Kroemer G. Molecular and Cellular Oncology: A new journal for a changing field. Molecular & Cellular Oncology. 1: e29052. PMID 27308308 DOI: 10.4161/Mco.29052 |
0.562 |
|
2014 |
Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, Apetoh L, Aranda F, Barnaba V, Bloy N, Bracci L, Breckpot K, Brough D, Buqué A, Castro MG, ... ... Galluzzi L, et al. Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology. 3: e955691. PMID 25941621 DOI: 10.4161/21624011.2014.955691 |
0.837 |
|
2014 |
Aranda F, Bloy N, Galluzzi L, Kroemer G, Senovilla L. Vitamin B6 improves the immunogenicity of cisplatin-induced cell death. Oncoimmunology. 3: e955685. PMID 25941619 DOI: 10.4161/21624011.2014.955685 |
0.498 |
|
2014 |
Bloy N, Pol J, Manic G, Vitale I, Eggermont A, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Radioimmunotherapy for oncological indications. Oncoimmunology. 3: e954929. PMID 25941606 DOI: 10.4161/21624011.2014.954929 |
0.46 |
|
2014 |
Galluzzi L, Kroemer G, Eggermont A. Novel immune checkpoint blocker approved for the treatment of advanced melanoma. Oncoimmunology. 3: e967147. PMID 25941597 DOI: 10.4161/21624011.2014.967147 |
0.463 |
|
2014 |
Bloy N, Pol J, Aranda F, Eggermont A, Cremer I, Fridman WH, Fučíková J, Galon J, Tartour E, Spisek R, Dhodapkar MV, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Dendritic cell-based anticancer therapy. Oncoimmunology. 3: e963424. PMID 25941593 DOI: 10.4161/21624011.2014.963424 |
0.422 |
|
2014 |
Vacchelli E, Aranda F, Eggermont A, Sautès-Fridman C, Tartour E, Kennedy EP, Platten M, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 3: e957994. PMID 25941578 DOI: 10.4161/21624011.2014.957994 |
0.71 |
|
2014 |
Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, et al. Classification of current anticancer immunotherapies. Oncotarget. 5: 12472-508. PMID 25537519 DOI: 10.18632/Oncotarget.2998 |
0.698 |
|
2014 |
Bonora M, Bravo-San Pedro JM, Kroemer G, Galluzzi L, Pinton P. Novel insights into the mitochondrial permeability transition. Cell Cycle (Georgetown, Tex.). 13: 2666-70. PMID 25486353 DOI: 10.4161/15384101.2014.949082 |
0.443 |
|
2014 |
Galluzzi L, Pietrocola F, Levine B, Kroemer G. Metabolic control of autophagy. Cell. 159: 1263-76. PMID 25480292 DOI: 10.1016/J.Cell.2014.11.006 |
0.668 |
|
2014 |
Green DR, Galluzzi L, Kroemer G. Cell biology. Metabolic control of cell death. Science (New York, N.Y.). 345: 1250256. PMID 25237106 DOI: 10.1126/Science.1250256 |
0.512 |
|
2014 |
Pol J, Bloy N, Obrist F, Eggermont A, Galon J, Cremer I, Erbs P, Limacher JM, Preville X, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch:: Oncolytic viruses for cancer therapy. Oncoimmunology. 3: e28694. PMID 25097804 DOI: 10.4161/Onci.28694 |
0.522 |
|
2014 |
Aranda F, Vacchelli E, Obrist F, Eggermont A, Galon J, Sautès-Fridman C, Cremer I, Henrik Ter Meulen J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Toll-like receptor agonists in oncological indications. Oncoimmunology. 3: e29179. PMID 25083332 DOI: 10.4161/Onci.29179 |
0.688 |
|
2014 |
Vacchelli E, Aranda F, Obrist F, Eggermont A, Galon J, Cremer I, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immunostimulatory cytokines in cancer therapy. Oncoimmunology. 3: e29030. PMID 25083328 DOI: 10.4161/Onci.29030 |
0.713 |
|
2014 |
Galluzzi L, Bravo-San Pedro JM, Kroemer G. Organelle-specific initiation of cell death. Nature Cell Biology. 16: 728-36. PMID 25082195 DOI: 10.1038/Ncb3005 |
0.542 |
|
2014 |
Sukkurwala AQ, Adjemian S, Senovilla L, Michaud M, Spaggiari S, Vacchelli E, Baracco EE, Galluzzi L, Zitvogel L, Kepp O, Kroemer G. Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set. Oncoimmunology. 3: e28473. PMID 25050214 DOI: 10.4161/Onci.28473 |
0.839 |
|
2014 |
Aranda F, Vacchelli E, Obrist F, Eggermont A, Galon J, Hervé Fridman W, Cremer I, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Adoptive cell transfer for anticancer immunotherapy. Oncoimmunology. 3: e28344. PMID 25050207 DOI: 10.4161/onci.28344 |
0.672 |
|
2014 |
Senovilla L, Aranda F, Galluzzi L, Kroemer G. Impact of myeloid cells on the efficacy of anticancer chemotherapy. Current Opinion in Immunology. 30: 24-31. PMID 24950501 DOI: 10.1016/J.Coi.2014.05.009 |
0.561 |
|
2014 |
Galluzzi L, Kroemer G. Preface: oncometabolism: a new field of research with profound therapeutic implications. Methods in Enzymology. 543: xv-xix. PMID 24924141 DOI: 10.1016/B978-0-12-801329-8.10000-5 |
0.344 |
|
2014 |
Scoazec M, Durand S, Chery A, Galluzzi L, Kroemer G. Metabolomic profiling of cultured cancer cells. Methods in Enzymology. 543: 165-78. PMID 24924132 DOI: 10.1016/B978-0-12-801329-8.00008-8 |
0.461 |
|
2014 |
Galluzzi L, Vitale I, Michels J, Brenner C, Szabadkai G, Harel-Bellan A, Castedo M, Kroemer G. Systems biology of cisplatin resistance: past, present and future. Cell Death & Disease. 5: e1257. PMID 24874729 DOI: 10.1038/Cddis.2013.428 |
0.765 |
|
2014 |
Pol J, Bloy N, Obrist F, Eggermont A, Galon J, Hervé Fridman W, Cremer I, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: DNA vaccines for cancer therapy. Oncoimmunology. 3: e28185. PMID 24800178 DOI: 10.4161/Onci.28185 |
0.476 |
|
2014 |
Vacchelli E, Aranda F, Eggermont A, Galon J, Sautès-Fridman C, Cremer I, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology. 3: e27878. PMID 24800173 DOI: 10.4161/Onci.27878 |
0.743 |
|
2014 |
Ma Y, Adjemian S, Galluzzi L, Zitvogel L, Kroemer G. Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy. Oncoimmunology. 3: e27663. PMID 24800170 DOI: 10.4161/Onci.27663 |
0.724 |
|
2014 |
Bonora M, Wieckowski MR, Chinopoulos C, Kepp O, Kroemer G, Galluzzi L, Pinton P. Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition. Oncogene. 34: 1475-86. PMID 24727893 DOI: 10.1038/Onc.2014.96 |
0.503 |
|
2014 |
Aranda F, Vacchelli E, Eggermont A, Galon J, Fridman WH, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy. Oncoimmunology. 3: e27297. PMID 24701370 DOI: 10.4161/Onci.27297 |
0.696 |
|
2014 |
Vacchelli E, Aranda F, Eggermont A, Galon J, Sautès-Fridman C, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy. Oncoimmunology. 3: e27048. PMID 24605265 DOI: 10.4161/Onci.27048 |
0.698 |
|
2014 |
Galluzzi L, Kepp O, Krautwald S, Kroemer G, Linkermann A. Molecular mechanisms of regulated necrosis. Seminars in Cell & Developmental Biology. 35: 24-32. PMID 24582829 DOI: 10.1016/J.Semcdb.2014.02.006 |
0.53 |
|
2014 |
Galluzzi L, Kepp O, Kroemer G. MLKL regulates necrotic plasma membrane permeabilization. Cell Research. 24: 139-40. PMID 24418759 DOI: 10.1038/Cr.2014.8 |
0.395 |
|
2014 |
Ma Y, Mattarollo SR, Adjemian S, Yang H, Aymeric L, Hannani D, Portela Catani JP, Duret H, Teng MW, Kepp O, Wang Y, Sistigu A, Schultze JL, Stoll G, Galluzzi L, et al. CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy. Cancer Research. 74: 436-45. PMID 24302580 DOI: 10.1158/0008-5472.Can-13-1265 |
0.817 |
|
2014 |
Martins I, Wang Y, Michaud M, Ma Y, Sukkurwala AQ, Shen S, Kepp O, Métivier D, Galluzzi L, Perfettini JL, Zitvogel L, Kroemer G. Molecular mechanisms of ATP secretion during immunogenic cell death. Cell Death and Differentiation. 21: 79-91. PMID 23852373 DOI: 10.1038/cdd.2013.75 |
0.811 |
|
2014 |
Sukkurwala AQ, Martins I, Wang Y, Schlemmer F, Ruckenstuhl C, Durchschlag M, Michaud M, Senovilla L, Sistigu A, Ma Y, Vacchelli E, Sulpice E, Gidrol X, Zitvogel L, Madeo F, ... Galluzzi L, et al. Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8. Cell Death and Differentiation. 21: 59-68. PMID 23787997 DOI: 10.1038/Cdd.2013.73 |
0.828 |
|
2014 |
Morselli E, Tasdemir E, Maiuri MC, Galluzzi L, Kepp O, Criollo A, Vicencio JM, Soussi T, Kroemer G. Erratum to Morselli E, et al. Cell Cycle 2008; 7:3056–61 Cell Cycle. 13: 2311-2311. DOI: 10.4161/Cc.29672 |
0.773 |
|
2014 |
Michels J, Goubar A, Adam J, Galluzzi L, Olaussen KA, Robin A, Girard P, Kremer I, Castedo M, Soria J, Kroemer G. Abstract 4691: Overactivation of poly (ADP-ribose) polymerase (PARP) in localised non-small cell lung cancer (NSCLC) predicts dismal prognosis Cancer Research. 74: 4691-4691. DOI: 10.1158/1538-7445.Am2014-4691 |
0.706 |
|
2013 |
Kroemer G, Galluzzi L, Zitvogel L. Immunological effects of chemotherapy in spontaneous breast cancers. Oncoimmunology. 2: e27158. PMID 24498568 DOI: 10.4161/Onci.27158 |
0.499 |
|
2013 |
Aranda F, Vacchelli E, Eggermont A, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Peptide vaccines in cancer therapy. Oncoimmunology. 2: e26621. PMID 24498550 DOI: 10.4161/onci.26621 |
0.661 |
|
2013 |
Semeraro M, Vacchelli E, Eggermont A, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Lenalidomide-based immunochemotherapy. Oncoimmunology. 2: e26494. PMID 24482747 DOI: 10.4161/Onci.26494 |
0.706 |
|
2013 |
Kepp O, Galluzzi L, Kroemer G. Immune effectors required for the therapeutic activity of vorinostat. Oncoimmunology. 2: e27157. PMID 24475375 DOI: 10.4161/Onci.27157 |
0.537 |
|
2013 |
Galluzzi L, Kepp O, Kroemer G. Immunogenic cell death in radiation therapy. Oncoimmunology. 2: e26536. PMID 24404424 DOI: 10.4161/Onci.26536 |
0.603 |
|
2013 |
Vacchelli E, Vitale I, Tartour E, Eggermont A, Sautès-Fridman C, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Anticancer radioimmunotherapy. Oncoimmunology. 2: e25595. PMID 24319634 DOI: 10.4161/Onci.25595 |
0.741 |
|
2013 |
Vacchelli E, Vitale I, Eggermont A, Fridman WH, Fučíková J, Cremer I, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Dendritic cell-based interventions for cancer therapy. Oncoimmunology. 2: e25771. PMID 24286020 DOI: 10.4161/onci.25771 |
0.666 |
|
2013 |
Galluzzi L, Kepp O, Vander Heiden MG, Kroemer G. Metabolic targets for cancer therapy. Nature Reviews. Drug Discovery. 12: 829-46. PMID 24113830 DOI: 10.1038/Nrd4145 |
0.449 |
|
2013 |
Vacchelli E, Eggermont A, Sautès-Fridman C, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Toll-like receptor agonists for cancer therapy. Oncoimmunology. 2: e25238. PMID 24083080 DOI: 10.4161/Onci.25238 |
0.668 |
|
2013 |
Vacchelli E, Eggermont A, Fridman WH, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulatory cytokines. Oncoimmunology. 2: e24850. PMID 24073369 DOI: 10.4161/Onci.24850 |
0.705 |
|
2013 |
Galluzzi L, Kroemer G. Common and divergent functions of Beclin 1 and Beclin 2. Cell Research. 23: 1341-2. PMID 24018378 DOI: 10.1038/Cr.2013.129 |
0.42 |
|
2013 |
Wang Y, Martins I, Ma Y, Kepp O, Galluzzi L, Kroemer G. Autophagy-dependent ATP release from dying cells via lysosomal exocytosis. Autophagy. 9: 1624-5. PMID 23989612 DOI: 10.4161/Auto.25873 |
0.667 |
|
2013 |
Lainey E, Wolfromm A, Sukkurwala AQ, Micol JB, Fenaux P, Galluzzi L, Kepp O, Kroemer G. EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells. Cell Cycle (Georgetown, Tex.). 12: 2978-91. PMID 23974111 DOI: 10.4161/Cc.26016 |
0.814 |
|
2013 |
Ma Y, Galluzzi L, Zitvogel L, Kroemer G. Autophagy and cellular immune responses. Immunity. 39: 211-27. PMID 23973220 DOI: 10.1016/J.Immuni.2013.07.017 |
0.562 |
|
2013 |
Jemaà M, Galluzzi L, Kepp O, Senovilla L, Brands M, Boemer U, Koppitz M, Lienau P, Prechtl S, Schulze V, Siemeister G, Wengner AM, Mumberg D, Ziegelbauer K, Abrieu A, et al. Characterization of novel MPS1 inhibitors with preclinical anticancer activity. Cell Death and Differentiation. 20: 1532-45. PMID 23933817 DOI: 10.1038/Cdd.2013.105 |
0.535 |
|
2013 |
Spaggiari S, Kepp O, Rello-Varona S, Chaba K, Adjemian S, Pype J, Galluzzi L, Lemaire M, Kroemer G. Antiapoptotic activity of argon and xenon. Cell Cycle (Georgetown, Tex.). 12: 2636-42. PMID 23907115 DOI: 10.4161/Cc.25650 |
0.768 |
|
2013 |
Vacchelli E, Prada N, Kepp O, Galluzzi L. Current trends of anticancer immunochemotherapy. Oncoimmunology. 2: e25396. PMID 23894726 DOI: 10.4161/Onci.25396 |
0.639 |
|
2013 |
Ma Y, Yamazaki T, Yang H, Kepp O, Galluzzi L, Zitvogel L, Smyth MJ, Kroemer G. Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy. Oncoimmunology. 2: e24786. PMID 23894723 DOI: 10.4161/Onci.24786 |
0.475 |
|
2013 |
Vacchelli E, Eggermont A, Sautès-Fridman C, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Oncolytic viruses for cancer therapy. Oncoimmunology. 2: e24612. PMID 23894720 DOI: 10.4161/onci.24612 |
0.671 |
|
2013 |
Ma Y, Adjemian S, Yang H, Catani JP, Hannani D, Martins I, Michaud M, Kepp O, Sukkurwala AQ, Vacchelli E, Galluzzi L, Zitvogel L, Kroemer G. ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy. Oncoimmunology. 2: e24568. PMID 23894718 DOI: 10.4161/Onci.24568 |
0.809 |
|
2013 |
Senovilla L, Galluzzi L, Zitvogel L, Kroemer G. Immunosurveillance as a regulator of tissue homeostasis. Trends in Immunology. 34: 471-81. PMID 23891238 DOI: 10.1016/J.It.2013.06.005 |
0.456 |
|
2013 |
Zitvogel L, Galluzzi L, Smyth MJ, Kroemer G. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity. 39: 74-88. PMID 23890065 DOI: 10.1016/J.Immuni.2013.06.014 |
0.544 |
|
2013 |
Mavilio D, Galluzzi L, Lugli E. Novel multifunctional antibody approved for the treatment of breast cancer. Oncoimmunology. 2: e24567. PMID 23802090 DOI: 10.4161/Onci.24567 |
0.396 |
|
2013 |
Kepp O, Menger L, Vacchelli E, Locher C, Adjemian S, Yamazaki T, Martins I, Sukkurwala AQ, Michaud M, Senovilla L, Galluzzi L, Kroemer G, Zitvogel L. Crosstalk between ER stress and immunogenic cell death. Cytokine & Growth Factor Reviews. 24: 311-8. PMID 23787159 DOI: 10.1016/J.Cytogfr.2013.05.001 |
0.817 |
|
2013 |
Vacchelli E, Eggermont A, Fridman WH, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Adoptive cell transfer for anticancer immunotherapy. Oncoimmunology. 2: e24238. PMID 23762803 DOI: 10.4161/Onci.24238 |
0.723 |
|
2013 |
Galluzzi L, Lugli E. Cancer immunotherapy turns viral. Oncoimmunology. 2: e24802. PMID 23734338 DOI: 10.4161/Onci.24802 |
0.455 |
|
2013 |
Senovilla L, Vacchelli E, Garcia P, Eggermont A, Fridman WH, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: DNA vaccines for cancer therapy. Oncoimmunology. 2: e23803. PMID 23734328 DOI: 10.4161/onci.23803 |
0.647 |
|
2013 |
Martins I, Kepp O, Menger L, Michaud M, Adjemian S, Sukkurwala AQ, Vacchelli E, Galluzzi L, Kroemer G. Fluorescent biosensors for the detection of HMGB1 release. Methods in Molecular Biology (Clifton, N.J.). 1004: 43-56. PMID 23733568 DOI: 10.1007/978-1-62703-383-1_4 |
0.823 |
|
2013 |
Pietrocola F, Izzo V, Niso-Santano M, Vacchelli E, Galluzzi L, Maiuri MC, Kroemer G. Regulation of autophagy by stress-responsive transcription factors. Seminars in Cancer Biology. 23: 310-22. PMID 23726895 DOI: 10.1016/J.Semcancer.2013.05.008 |
0.788 |
|
2013 |
Vacchelli E, Senovilla L, Eggermont A, Fridman WH, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology. 2: e23510. PMID 23687621 DOI: 10.4161/onci.23510 |
0.704 |
|
2013 |
Senovilla L, Galluzzi L, Castedo M, Kroemer G. Immunological control of cell cycle aberrations for the avoidance of oncogenesis: the case of tetraploidy. Annals of the New York Academy of Sciences. 1284: 57-61. PMID 23651194 DOI: 10.1111/Nyas.12072 |
0.567 |
|
2013 |
Brenner C, Galluzzi L, Kepp O, Kroemer G. Decoding cell death signals in liver inflammation. Journal of Hepatology. 59: 583-94. PMID 23567086 DOI: 10.1016/J.Jhep.2013.03.033 |
0.482 |
|
2013 |
Ma Y, Adjemian S, Mattarollo SR, Yamazaki T, Aymeric L, Yang H, Portela Catani JP, Hannani D, Duret H, Steegh K, Martins I, Schlemmer F, Michaud M, Kepp O, Sukkurwala AQ, ... ... Galluzzi L, et al. Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity. 38: 729-41. PMID 23562161 DOI: 10.1016/J.Immuni.2013.03.003 |
0.837 |
|
2013 |
Michels J, Vitale I, Galluzzi L, Adam J, Olaussen KA, Kepp O, Senovilla L, Talhaoui I, Guegan J, Enot DP, Talbot M, Robin A, Girard P, Oréar C, Lissa D, et al. Cisplatin resistance associated with PARP hyperactivation. Cancer Research. 73: 2271-80. PMID 23554447 DOI: 10.1158/0008-5472.Can-12-3000 |
0.84 |
|
2013 |
Michels J, Kepp O, Senovilla L, Lissa D, Castedo M, Kroemer G, Galluzzi L. Functions of BCL-X L at the Interface between Cell Death and Metabolism. International Journal of Cell Biology. 2013: 705294. PMID 23533418 DOI: 10.1155/2013/705294 |
0.822 |
|
2013 |
Galluzzi L, Lugli E. Rejuvenated T cells attack old tumors. Oncoimmunology. 2: e24103. PMID 23526137 DOI: 10.4161/Onci.24103 |
0.411 |
|
2013 |
Menger L, Vacchelli E, Kepp O, Eggermont A, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Cardiac glycosides and cancer therapy. Oncoimmunology. 2: e23082. PMID 23525565 DOI: 10.4161/Onci.23082 |
0.79 |
|
2013 |
Senovilla L, Vitale I, Martins I, Kepp O, Galluzzi L, Zitvogel L, Castedo M, Kroemer G. An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells. Oncoimmunology. 2: e22409. PMID 23482968 DOI: 10.4161/Onci.22409 |
0.535 |
|
2013 |
Vacchelli E, Eggermont A, Galon J, Sautès-Fridman C, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Monoclonal antibodies in cancer therapy. Oncoimmunology. 2: e22789. PMID 23482847 DOI: 10.4161/onci.22789 |
0.672 |
|
2013 |
Bonora M, Bononi A, De Marchi E, Giorgi C, Lebiedzinska M, Marchi S, Patergnani S, Rimessi A, Suski JM, Wojtala A, Wieckowski MR, Kroemer G, Galluzzi L, Pinton P. Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell Cycle (Georgetown, Tex.). 12: 674-83. PMID 23343770 DOI: 10.4161/Cc.23599 |
0.463 |
|
2013 |
Galluzzi L, Goubar A, Olaussen KA, Vitale I, Senovilla L, Michels J, Robin A, Dorvault N, Besse B, Validire P, Fouret P, Behrens C, Wistuba II, Soria JC, Kroemer G. Prognostic value of LIPC in non-small cell lung carcinoma. Cell Cycle (Georgetown, Tex.). 12: 647-54. PMID 23343765 DOI: 10.4161/Cc.23517 |
0.715 |
|
2013 |
Galluzzi L, Vacchelli E, Michels J, Garcia P, Kepp O, Senovilla L, Vitale I, Kroemer G. Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses. Oncogene. 32: 4995-5004. PMID 23334322 DOI: 10.1038/Onc.2012.623 |
0.783 |
|
2013 |
Boilève A, Senovilla L, Vitale I, Lissa D, Martins I, Métivier D, van den Brink S, Clevers H, Galluzzi L, Castedo M, Kroemer G. Immunosurveillance against tetraploidization-induced colon tumorigenesis. Cell Cycle (Georgetown, Tex.). 12: 473-9. PMID 23324343 DOI: 10.4161/Cc.23369 |
0.796 |
|
2013 |
Kepp O, Martins I, Menger L, Michaud M, Adjemian S, Sukkurwala AQ, Galluzzi L, Kroemer G. Quantification of cell cycle-arresting proteins. Methods in Molecular Biology (Clifton, N.J.). 965: 121-42. PMID 23296654 DOI: 10.1007/978-1-62703-239-1_7 |
0.815 |
|
2013 |
Vitale I, Jemaà M, Galluzzi L, Metivier D, Castedo M, Kroemer G. Cytofluorometric assessment of cell cycle progression. Methods in Molecular Biology (Clifton, N.J.). 965: 93-120. PMID 23296653 DOI: 10.1007/978-1-62703-239-1_6 |
0.754 |
|
2013 |
Galluzzi L, Marsili S, Vitale I, Senovilla L, Michels J, Garcia P, Vacchelli E, Chatelut E, Castedo M, Kroemer G. Vitamin B6 metabolism influences the intracellular accumulation of cisplatin. Cell Cycle (Georgetown, Tex.). 12: 417-21. PMID 23287530 DOI: 10.4161/Cc.23275 |
0.807 |
|
2013 |
Jemaà M, Galluzzi L, Kepp O, Castedo M, Rello-Varona S, Vitale I, Kroemer G. Transgenerational cell fate profiling: a method for the graphical presentation of complex cell cycle alterations. Cell Cycle (Georgetown, Tex.). 12: 183-90. PMID 23255111 DOI: 10.4161/Cc.23046 |
0.77 |
|
2013 |
Niso-Santano M, Shen S, Adjemian S, Malik SA, Mariño G, Lachkar S, Senovilla L, Kepp O, Galluzzi L, Maiuri MC, Kroemer G. Direct interaction between STAT3 and EIF2AK2 controls fatty acid-induced autophagy. Autophagy. 9: 415-7. PMID 23221979 DOI: 10.4161/Auto.22910 |
0.804 |
|
2013 |
Galluzzi L, Kepp O, Kroemer G. Mitochondria: master regulators of danger signalling. Nature Reviews. Molecular Cell Biology. 13: 780-8. PMID 23175281 DOI: 10.1038/Nrm3479 |
0.505 |
|
2013 |
Senovilla L, Galluzzi L, Marino G, Vitale I, Castedo M, Kroemer G. Immunosurveillance against cancer-associated hyperploidy. Oncotarget. 3: 1270-1. PMID 23174699 DOI: 10.18632/Oncotarget.753 |
0.596 |
|
2013 |
Lainey E, Wolfromm A, Marie N, Enot D, Scoazec M, Bouteloup C, Leroy C, Micol JB, De Botton S, Galluzzi L, Fenaux P, Kroemer G. Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia. Oncogene. 32: 4331-42. PMID 23085751 DOI: 10.1038/Onc.2012.469 |
0.747 |
|
2013 |
Galluzzi L, Kepp O, Trojel-Hansen C, Kroemer G. Mitochondrial control of cellular life, stress, and death. Circulation Research. 111: 1198-207. PMID 23065343 DOI: 10.1161/Circresaha.112.268946 |
0.536 |
|
2013 |
Wengner A, Jemaà M, Galluzzi L, Kepp O, Brands M, Koppitz M, Schulze V, Siemeister G, Mumberg D, Ziegelbauer K, Castedo M, Vitale I, Kroemer G. Abstract 706: Novel MPS1 inhibitors with potential anticancer activity. Cancer Research. 73: 706-706. DOI: 10.1158/1538-7445.Am2013-706 |
0.76 |
|
2013 |
Galluzzi L, Kepp O, Heiden MGV, Kroemer G. Erratum: Metabolic targets for cancer therapy Nature Reviews Drug Discovery. 12: 963-963. DOI: 10.1038/Nrd4191 |
0.432 |
|
2013 |
Criollo A, Galluzzi L, Chiara Maiuri M, Tasdemir E, Lavandero S, Kroemer G. Erratum to: Mitochondrial control of cell death induced by hyperosmotic stress Apoptosis. 18: 535-536. DOI: 10.1007/S10495-013-0817-7 |
0.742 |
|
2012 |
Kepp O, Menger L, Vacchelli E, Adjemian S, Martins I, Ma Y, Sukkurwala AQ, Michaud M, Galluzzi L, Zitvogel L, Kroemer G. Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects. Oncoimmunology. 1: 1640-1642. PMID 23264921 DOI: 10.4161/Onci.21684 |
0.815 |
|
2012 |
Vacchelli E, Martins I, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Peptide vaccines in cancer therapy. Oncoimmunology. 1: 1557-1576. PMID 23264902 DOI: 10.4161/Onci.22428 |
0.681 |
|
2012 |
Senovilla L, Vacchelli E, Galon J, Adjemian S, Eggermont A, Fridman WH, Sautès-Fridman C, Ma Y, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Prognostic and predictive value of the immune infiltrate in cancer. Oncoimmunology. 1: 1323-1343. PMID 23243596 DOI: 10.4161/Onci.22009 |
0.823 |
|
2012 |
Galluzzi L, Senovilla L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Trial watch: Dendritic cell-based interventions for cancer therapy. Oncoimmunology. 1: 1111-1134. PMID 23170259 DOI: 10.4161/Onci.21494 |
0.692 |
|
2012 |
Vacchelli E, Galluzzi L, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy. Oncoimmunology. 1: 894-907. PMID 23162757 DOI: 10.4161/Onci.20931 |
0.684 |
|
2012 |
Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annual Review of Immunology. 31: 51-72. PMID 23157435 DOI: 10.1146/Annurev-Immunol-032712-100008 |
0.579 |
|
2012 |
Tanchot C, Terme M, Pere H, Tran T, Benhamouda N, Strioga M, Banissi C, Galluzzi L, Kroemer G, Tartour E. Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 6: 147-57. PMID 23104434 DOI: 10.1007/S12307-012-0122-Y |
0.519 |
|
2012 |
Lainey E, Sébert M, Thépot S, Scoazec M, Bouteloup C, Leroy C, De Botton S, Galluzzi L, Fenaux P, Kroemer G. Erlotinib antagonizes ABC transporters in acute myeloid leukemia. Cell Cycle (Georgetown, Tex.). 11: 4079-92. PMID 23095522 DOI: 10.4161/Cc.22382 |
0.732 |
|
2012 |
Shen S, Niso-Santano M, Adjemian S, Takehara T, Malik SA, Minoux H, Souquere S, Mariño G, Lachkar S, Senovilla L, Galluzzi L, Kepp O, Pierron G, Maiuri MC, Hikita H, et al. Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity. Molecular Cell. 48: 667-80. PMID 23084476 DOI: 10.1016/J.Molcel.2012.09.013 |
0.8 |
|
2012 |
Pietrocola F, Mariño G, Lissa D, Vacchelli E, Malik SA, Niso-Santano M, Zamzami N, Galluzzi L, Maiuri MC, Kroemer G. Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteins. Cell Cycle (Georgetown, Tex.). 11: 3851-60. PMID 23070521 DOI: 10.4161/Cc.22027 |
0.797 |
|
2012 |
Senovilla L, Vitale I, Martins I, Tailler M, Pailleret C, Michaud M, Galluzzi L, Adjemian S, Kepp O, Niso-Santano M, Shen S, Mariño G, Criollo A, Boilève A, Job B, et al. An immunosurveillance mechanism controls cancer cell ploidy. Science (New York, N.Y.). 337: 1678-84. PMID 23019653 DOI: 10.1126/Science.1224922 |
0.835 |
|
2012 |
Galluzzi L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Trial Watch: Experimental Toll-like receptor agonists for cancer therapy. Oncoimmunology. 1: 699-716. PMID 22934262 DOI: 10.4161/Onci.20696 |
0.697 |
|
2012 |
Galluzzi L, Vitale I, Senovilla L, Eisenberg T, Carmona-Gutierrez D, Vacchelli E, Robert T, Ripoche H, Jägemann N, Paccard C, Servant N, Hupé P, Lazar V, Dessen P, Barillot E, et al. Independent transcriptional reprogramming and apoptosis induction by cisplatin. Cell Cycle (Georgetown, Tex.). 11: 3472-80. PMID 22918244 DOI: 10.4161/Cc.21789 |
0.737 |
|
2012 |
Galluzzi L, Vitale I, Senovilla L, Olaussen KA, Pinna G, Eisenberg T, Goubar A, Martins I, Michels J, Kratassiouk G, Carmona-Gutierrez D, Scoazec M, Vacchelli E, Schlemmer F, Kepp O, et al. Prognostic impact of vitamin B6 metabolism in lung cancer. Cell Reports. 2: 257-69. PMID 22854025 DOI: 10.1016/J.Celrep.2012.06.017 |
0.796 |
|
2012 |
Menger L, Vacchelli E, Adjemian S, Martins I, Ma Y, Shen S, Yamazaki T, Sukkurwala AQ, Michaud M, Mignot G, Schlemmer F, Sulpice E, Locher C, Gidrol X, Ghiringhelli F, ... ... Galluzzi L, et al. Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Science Translational Medicine. 4: 143ra99. PMID 22814852 DOI: 10.1126/Scitranslmed.3003807 |
0.827 |
|
2012 |
Vacchelli E, Galluzzi L, Eggermont A, Galon J, Tartour E, Zitvogel L, Kroemer G. Trial Watch: Immunostimulatory cytokines. Oncoimmunology. 1: 493-506. PMID 22754768 DOI: 10.4161/onci.20459 |
0.703 |
|
2012 |
Galluzzi L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Trial Watch: Adoptive cell transfer immunotherapy. Oncoimmunology. 1: 306-315. PMID 22737606 DOI: 10.4161/Onci.19549 |
0.735 |
|
2012 |
Vacchelli E, Galluzzi L, Rousseau V, Rigoni A, Tesniere A, Delahaye N, Schlemmer FD, Menger L, Sukkurwala AQ, Adjemian S, Martins I, Michaud M, Dunant A, Kepp O, Brambilla E, et al. Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer. Oncoimmunology. 1: 271-278. PMID 22737602 DOI: 10.4161/Onci.18684 |
0.808 |
|
2012 |
Vacchelli E, Galluzzi L, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Kroemer G. Trial watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology. 1: 179-188. PMID 22720239 DOI: 10.4161/onci.1.2.19026 |
0.726 |
|
2012 |
Galluzzi L, Vacchelli E, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zucman-Rossi J, Zitvogel L, Kroemer G. Trial Watch: Monoclonal antibodies in cancer therapy. Oncoimmunology. 1: 28-37. PMID 22720209 DOI: 10.4161/Onci.1.1.17938 |
0.709 |
|
2012 |
Ladoire S, Chaba K, Martins I, Sukkurwala AQ, Adjemian S, Michaud M, Poirier-Colame V, Andreiuolo F, Galluzzi L, White E, Rosenfeldt M, Ryan KM, Zitvogel L, Kroemer G. Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens. Autophagy. 8: 1175-84. PMID 22647537 DOI: 10.4161/Auto.20353 |
0.812 |
|
2012 |
Jemaà M, Galluzzi L, Kepp O, Boilève A, Lissa D, Senovilla L, Harper F, Pierron G, Berardinelli F, Antoccia A, Castedo M, Vitale I, Kroemer G. Preferential killing of p53-deficient cancer cells by reversine. Cell Cycle (Georgetown, Tex.). 11: 2149-58. PMID 22592527 DOI: 10.4161/Cc.20621 |
0.834 |
|
2012 |
Galluzzi L, Kroemer G. Autophagy mediates the metabolic benefits of endurance training. Circulation Research. 110: 1276-8. PMID 22581920 DOI: 10.1161/Res.0B013E318259E70B |
0.532 |
|
2012 |
Jemaà M, Vitale I, Kepp O, Berardinelli F, Galluzzi L, Senovilla L, Mariño G, Malik SA, Rello-Varona S, Lissa D, Antoccia A, Tailler M, Schlemmer F, Harper F, Pierron G, et al. Selective killing of p53-deficient cancer cells by SP600125. Embo Molecular Medicine. 4: 500-14. PMID 22438244 DOI: 10.1002/Emmm.201200228 |
0.818 |
|
2012 |
Zitvogel L, Kepp O, Galluzzi L, Kroemer G. Inflammasomes in carcinogenesis and anticancer immune responses. Nature Immunology. 13: 343-51. PMID 22430787 DOI: 10.1038/Ni.2224 |
0.56 |
|
2012 |
Galluzzi L, Kepp O, Trojel-Hansen C, Kroemer G. Non-apoptotic functions of apoptosis-regulatory proteins. Embo Reports. 13: 322-30. PMID 22402666 DOI: 10.1038/Embor.2012.19 |
0.528 |
|
2012 |
Martins I, Michaud M, Sukkurwala AQ, Adjemian S, Ma Y, Shen S, Kepp O, Menger L, Vacchelli E, Galluzzi L, Zitvogel L, Kroemer G. Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death. Autophagy. 8: 413-5. PMID 22361584 DOI: 10.4161/Auto.19009 |
0.845 |
|
2012 |
Galluzzi L, Kepp O, Kroemer G. Reverse Warburg: straight to cancer. Cell Cycle (Georgetown, Tex.). 11: 1059. PMID 22343921 DOI: 10.4161/Cc.11.6.19746 |
0.417 |
|
2012 |
Niso-Santano M, Criollo A, Malik SA, Michaud M, Morselli E, Mariño G, Lachkar S, Galluzzi L, Maiuri MC, Kroemer G. Direct molecular interactions between Beclin 1 and the canonical NFκB activation pathway. Autophagy. 8: 268-70. PMID 22301997 DOI: 10.4161/Auto.8.2.18845 |
0.807 |
|
2012 |
Galluzzi L, Senovilla L, Zitvogel L, Kroemer G. The secret ally: immunostimulation by anticancer drugs. Nature Reviews. Drug Discovery. 11: 215-33. PMID 22301798 DOI: 10.1038/Nrd3626 |
0.488 |
|
2012 |
Galluzzi L, Kepp O, Kroemer G. Enlightening the impact of immunogenic cell death in photodynamic cancer therapy. The Embo Journal. 31: 1055-7. PMID 22252132 DOI: 10.1038/Emboj.2012.2 |
0.514 |
|
2012 |
Galluzzi L, Kroemer G. Necroptosis turns TNF lethal. Immunity. 35: 849-51. PMID 22195740 DOI: 10.1016/J.Immuni.2011.12.004 |
0.44 |
|
2012 |
Criollo A, Chereau F, Malik SA, Niso-Santano M, Mariño G, Galluzzi L, Maiuri MC, Baud V, Kroemer G. Autophagy is required for the activation of NFκB. Cell Cycle (Georgetown, Tex.). 11: 194-9. PMID 22186785 DOI: 10.4161/Cc.11.1.18669 |
0.77 |
|
2012 |
Galluzzi L, Morselli E, Kepp O, Vitale I, Younes AB, Maiuri MC, Kroemer G. Evaluation of rapamycin-induced cell death. Methods in Molecular Biology (Clifton, N.J.). 821: 125-69. PMID 22125064 DOI: 10.1007/978-1-61779-430-8_9 |
0.756 |
|
2012 |
Hannani D, Sistigu A, Kepp O, Galluzzi L, Kroemer G, Zitvogel L. Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy. Cancer Journal (Sudbury, Mass.). 17: 351-8. PMID 21952286 DOI: 10.1097/Ppo.0B013E3182325D4D |
0.583 |
|
2012 |
Martins I, Galluzzi L, Kroemer G. Hormesis, cell death and aging. Aging. 3: 821-8. PMID 21931183 DOI: 10.18632/AGING.100380 |
0.416 |
|
2012 |
Galluzzi L, Vanden Berghe T, Vanlangenakker N, Buettner S, Eisenberg T, Vandenabeele P, Madeo F, Kroemer G. Programmed necrosis from molecules to health and disease. International Review of Cell and Molecular Biology. 289: 1-35. PMID 21749897 DOI: 10.1016/B978-0-12-386039-2.00001-8 |
0.504 |
|
2012 |
Criollo A, Chereau F, Malik SA, Niso-Santano M, Mariño G, Galluzzi L, Maiuri MC, Baud V, Kroemer G. Erratum to Criollo A, et al. Cell Cycle Volume 11, Issue 1; pp. 194-9 Cell Cycle. 11: 4673-4673. DOI: 10.4161/cc.23148 |
0.679 |
|
2012 |
Michels J, Vitale I, Galluzzi L, Kepp O, Senovilla L, Olaussen KA, Soria J, Castedo M, Kroemer G. Abstract 3115: PARP overactivation predicts the susceptibility of human cancer cells to apoptosis induction by PARP inhibitors Cancer Research. 72: 3115-3115. DOI: 10.1158/1538-7445.Am2012-3115 |
0.773 |
|
2011 |
Galluzzi L, Vitale I, Vacchelli E, Kroemer G. Cell death signaling and anticancer therapy. Frontiers in Oncology. 1: 5. PMID 22655227 DOI: 10.3389/Fonc.2011.00005 |
0.758 |
|
2011 |
Galluzzi L, Kroemer G. The grand challenges to cellular and molecular oncology. Frontiers in Oncology. 1: 2. PMID 22655225 DOI: 10.3389/Fonc.2011.00002 |
0.548 |
|
2011 |
Galluzzi L, Vitale I, Kroemer G. Past, present, and future of molecular and cellular oncology. Frontiers in Oncology. 1: 1. PMID 22655224 DOI: 10.3389/Fonc.2011.00001 |
0.549 |
|
2011 |
Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, Shen S, Kepp O, Scoazec M, Mignot G, Rello-Varona S, Tailler M, Menger L, Vacchelli E, Galluzzi L, et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science (New York, N.Y.). 334: 1573-7. PMID 22174255 DOI: 10.1126/Science.1208347 |
0.837 |
|
2011 |
Tailler M, Senovilla L, Lainey E, Thépot S, Métivier D, Sébert M, Baud V, Billot K, Fenaux P, Galluzzi L, Boehrer S, Kroemer G, Kepp O. Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia. Oncogene. 31: 3536-46. PMID 22105358 DOI: 10.1038/Onc.2011.521 |
0.837 |
|
2011 |
Criollo A, Niso-Santano M, Malik SA, Michaud M, Morselli E, Mariño G, Lachkar S, Arkhipenko AV, Harper F, Pierron G, Rain JC, Ninomiya-Tsuji J, Fuentes JM, Lavandero S, Galluzzi L, et al. Inhibition of autophagy by TAB2 and TAB3. The Embo Journal. 30: 4908-20. PMID 22081109 DOI: 10.1038/Emboj.2011.413 |
0.802 |
|
2011 |
Galluzzi L, Kepp O, Kroemer G. Caspase-3 and prostaglandins signal for tumor regrowth in cancer therapy. Oncogene. 31: 2805-8. PMID 21963852 DOI: 10.1038/Onc.2011.459 |
0.573 |
|
2011 |
Boehrer S, Galluzzi L, Lainey E, Bouteloup C, Tailler M, Harper F, Pierron G, Adès L, Thépot S, Sébert M, Gardin C, de Botton S, Fenaux P, Kroemer G. Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia. Cell Cycle (Georgetown, Tex.). 10: 3168-75. PMID 21897118 DOI: 10.4161/Cc.10.18.16599 |
0.811 |
|
2011 |
Galluzzi L, Kepp O, Kroemer G. FADD: an endogenous inhibitor of RIP3-driven regulated necrosis. Cell Research. 21: 1383-5. PMID 21894190 DOI: 10.1038/Cr.2011.147 |
0.487 |
|
2011 |
Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G. Molecular mechanisms of cisplatin resistance. Oncogene. 31: 1869-83. PMID 21892204 DOI: 10.1038/Onc.2011.384 |
0.722 |
|
2011 |
Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science (New York, N.Y.). 333: 1109-12. PMID 21868666 DOI: 10.1126/Science.1201940 |
0.5 |
|
2011 |
Galluzzi L, Kepp O, Kroemer G. Autophagy and innate immunity ally against bacterial invasion. The Embo Journal. 30: 3213-4. PMID 21785408 DOI: 10.1038/Emboj.2011.244 |
0.438 |
|
2011 |
Morselli E, Shen S, Ruckenstuhl C, Bauer MA, Mariño G, Galluzzi L, Criollo A, Michaud M, Maiuri MC, Chano T, Madeo F, Kroemer G. p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200. Cell Cycle (Georgetown, Tex.). 10: 2763-9. PMID 21775823 DOI: 10.4161/Cc.10.16.16868 |
0.689 |
|
2011 |
Castedo M, Galluzzi L, Vitale I, Senovilla L, Métivier D, Jèmaà M, Rello-Varona S, Kroemer G. Cytofluorometric purification of diploid and tetraploid cancer cells. Methods in Molecular Biology (Clifton, N.J.). 761: 47-63. PMID 21755440 DOI: 10.1007/978-1-61779-182-6_3 |
0.749 |
|
2011 |
Galluzzi L, Kepp O, Kroemer G. Mitochondrial dynamics: a strategy for avoiding autophagy. Current Biology : Cb. 21: R478-80. PMID 21683905 DOI: 10.1016/J.Cub.2011.05.002 |
0.531 |
|
2011 |
Büttner S, Ruli D, Vögtle FN, Galluzzi L, Moitzi B, Eisenberg T, Kepp O, Habernig L, Carmona-Gutierrez D, Rockenfeller P, Laun P, Breitenbach M, Khoury C, Fröhlich KU, Rechberger G, et al. A yeast BH3-only protein mediates the mitochondrial pathway of apoptosis Embo Journal. 30: 2779-2792. PMID 21673659 DOI: 10.1038/Emboj.2011.197 |
0.511 |
|
2011 |
Galluzzi L, Kepp O, Kroemer G. Viperin turns coat in cytomegalovirus infection. Developmental Cell. 20: 737-8. PMID 21664572 DOI: 10.1016/J.Devcel.2011.05.016 |
0.406 |
|
2011 |
Thépot S, Lainey E, Cluzeau T, Sébert M, Leroy C, Adès L, Tailler M, Galluzzi L, Baran-Marszak F, Roudot H, Eclache V, Gardin C, de Botton S, Auberger P, Fenaux P, et al. Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia. Cell Cycle (Georgetown, Tex.). 10: 2323-30. PMID 21654193 DOI: 10.4161/Cc.10.14.16399 |
0.818 |
|
2011 |
Vitale I, Galluzzi L, Castedo M, Kroemer G. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nature Reviews. Molecular Cell Biology. 12: 385-92. PMID 21527953 DOI: 10.1038/Nrm3115 |
0.487 |
|
2011 |
Mariño G, Morselli E, Bennetzen MV, Eisenberg T, Megalou E, Schroeder S, Cabrera S, Bénit P, Rustin P, Criollo A, Kepp O, Galluzzi L, Shen S, Malik SA, Maiuri MC, et al. Longevity-relevant regulation of autophagy at the level of the acetylproteome. Autophagy. 7: 647-9. PMID 21460620 DOI: 10.4161/Auto.7.6.15191 |
0.811 |
|
2011 |
Rello-Varona S, Kepp O, Vitale I, Michaud M, Senovilla L, Jemaà M, Joza N, Galluzzi L, Castedo M, Kroemer G. An automated fluorescence videomicroscopy assay for the detection of mitotic catastrophe. Cell Death & Disease. 1: e25. PMID 21364633 DOI: 10.1038/Cddis.2010.6 |
0.472 |
|
2011 |
Zischka H, Lichtmannegger J, Schmitt S, Jägemann N, Schulz S, Wartini D, Jennen L, Rust C, Larochette N, Galluzzi L, Chajes V, Bandow N, Gilles VS, DiSpirito AA, Esposito I, et al. Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease. The Journal of Clinical Investigation. 121: 1508-18. PMID 21364284 DOI: 10.1172/Jci45401 |
0.404 |
|
2011 |
Kepp O, Galluzzi L, Lipinski M, Yuan J, Kroemer G. Cell death assays for drug discovery. Nature Reviews. Drug Discovery. 10: 221-37. PMID 21358741 DOI: 10.1038/Nrd3373 |
0.525 |
|
2011 |
Morselli E, Mariño G, Bennetzen MV, Eisenberg T, Megalou E, Schroeder S, Cabrera S, Bénit P, Rustin P, Criollo A, Kepp O, Galluzzi L, Shen S, Malik SA, Maiuri MC, et al. Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. The Journal of Cell Biology. 192: 615-29. PMID 21339330 DOI: 10.1083/Jcb.201008167 |
0.822 |
|
2011 |
Kepp O, Galluzzi L, Kroemer G. Mitochondrial control of the NLRP3 inflammasome. Nature Immunology. 12: 199-200. PMID 21321591 DOI: 10.1038/Ni0311-199 |
0.448 |
|
2011 |
Kepp O, Galluzzi L, Martins I, Schlemmer F, Adjemian S, Michaud M, Sukkurwala AQ, Menger L, Zitvogel L, Kroemer G. Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Reviews. 30: 61-9. PMID 21249425 DOI: 10.1007/S10555-011-9273-4 |
0.835 |
|
2011 |
Galluzzi L, Kepp O, Kroemer G. TP53 and MTOR crosstalk to regulate cellular senescence. Aging. 2: 535-7. PMID 20876940 DOI: 10.18632/AGING.100202 |
0.436 |
|
2011 |
Galluzzi L, Morselli E, Kepp O, Vitale I, Pinti M, Kroemer G. Mitochondrial liaisons of p53. Antioxidants & Redox Signaling. 15: 1691-714. PMID 20712408 DOI: 10.1089/Ars.2010.3504 |
0.732 |
|
2011 |
Morselli E, Galluzzi L, Kepp O, Mariño G, Michaud M, Vitale I, Maiuri MC, Kroemer G. Oncosuppressive functions of autophagy. Antioxidants & Redox Signaling. 14: 2251-69. PMID 20712403 DOI: 10.1089/Ars.2010.3478 |
0.737 |
|
2011 |
Galluzzi L, Kepp O, Kroemer G. A new role for cytoplasmic p53: binding and destroying double-stranded RNA. Cell Cycle (Georgetown, Tex.). 9: 2491-2. PMID 20647755 DOI: 10.4161/Cc.9.13.12191 |
0.497 |
|
2010 |
Morselli E, Maiuri MC, Markaki M, Megalou E, Pasparaki A, Palikaras K, Criollo A, Galluzzi L, Malik SA, Vitale I, Michaud M, Madeo F, Tavernarakis N, Kroemer G. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death & Disease. 1: e10. PMID 21364612 DOI: 10.1038/Cddis.2009.8 |
0.829 |
|
2010 |
Vitale I, Galluzzi L, Senovilla L, Criollo A, Jemaà M, Castedo M, Kroemer G. Illicit survival of cancer cells during polyploidization and depolyploidization. Cell Death and Differentiation. 18: 1403-13. PMID 21072053 DOI: 10.1038/Cdd.2010.145 |
0.751 |
|
2010 |
Martins I, Kepp O, Galluzzi L, Senovilla L, Schlemmer F, Adjemian S, Menger L, Michaud M, Zitvogel L, Kroemer G. Surface-exposed calreticulin in the interaction between dying cells and phagocytes. Annals of the New York Academy of Sciences. 1209: 77-82. PMID 20958319 DOI: 10.1111/J.1749-6632.2010.05740.X |
0.821 |
|
2010 |
Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nature Reviews. Molecular Cell Biology. 11: 700-14. PMID 20823910 DOI: 10.1038/Nrm2970 |
0.494 |
|
2010 |
Vitale I, Jemaà M, Senovilla L, Galluzzi L, Rello-Varona S, Metivier D, Ripoche H, Lazar V, Dessen P, Castedo M, Kroemer G. Involvement of p38alpha in the mitotic progression of p53(-/-) tetraploid cells. Cell Cycle (Georgetown, Tex.). 9: 2823-9. PMID 20686359 |
0.712 |
|
2010 |
Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nature Reviews. Drug Discovery. 9: 447-64. PMID 20467424 DOI: 10.1038/Nrd3137 |
0.51 |
|
2010 |
Galluzzi L, Kepp O, Morselli E, Vitale I, Senovilla L, Pinti M, Zitvogel L, Kroemer G. Viral strategies for the evasion of immunogenic cell death. Journal of Internal Medicine. 267: 526-42. PMID 20433579 DOI: 10.1111/J.1365-2796.2010.02223.X |
0.731 |
|
2010 |
Kepp O, Galluzzi L, Zitvogel L, Kroemer G. Pyroptosis - a cell death modality of its kind? European Journal of Immunology. 40: 627-30. PMID 20201017 DOI: 10.1002/Eji.200940160 |
0.519 |
|
2010 |
Vitale I, Senovilla L, Jemaà M, Michaud M, Galluzzi L, Kepp O, Nanty L, Criollo A, Rello-Varona S, Manic G, Métivier D, Vivet S, Tajeddine N, Joza N, Valent A, et al. Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos. The Embo Journal. 29: 1272-84. PMID 20186124 DOI: 10.1038/Emboj.2010.11 |
0.733 |
|
2010 |
Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, Criollo A, Servant N, Paccard C, Hupé P, Robert T, Ripoche H, Lazar V, Harel-Bellan A, Dessen P, Barillot E, et al. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Research. 70: 1793-803. PMID 20145152 DOI: 10.1158/0008-5472.Can-09-3112 |
0.661 |
|
2010 |
Galluzzi L, Kepp O, Zitvogel L, Kroemer G. Bacterial invasion: linking autophagy and innate immunity. Current Biology : Cb. 20: R106-8. PMID 20144769 DOI: 10.1016/J.Cub.2009.12.016 |
0.413 |
|
2010 |
Criollo A, Senovilla L, Authier H, Maiuri MC, Morselli E, Vitale I, Kepp O, Tasdemir E, Galluzzi L, Shen S, Tailler M, Delahaye N, Tesniere A, De Stefano D, Younes AB, et al. IKK connects autophagy to major stress pathways. Autophagy. 6: 189-91. PMID 20110771 DOI: 10.4161/Auto.6.1.10818 |
0.802 |
|
2010 |
Maiuri MC, Galluzzi L, Morselli E, Kepp O, Malik SA, Kroemer G. Autophagy regulation by p53. Current Opinion in Cell Biology. 22: 181-5. PMID 20044243 DOI: 10.1016/J.Ceb.2009.12.001 |
0.823 |
|
2010 |
Morselli E, Maiuri MC, Markaki M, Megalou E, Pasparaki A, Palikaras K, Criollo A, Galluzzi L, Malik SA, Vitale I, Michaud M, Madeo F, Tavernarakis N, Kroemer G. The life span-prolonging effect of sirtuin-1 is mediated by autophagy. Autophagy. 6: 186-8. PMID 20023410 DOI: 10.4161/Auto.6.1.10817 |
0.829 |
|
2010 |
Galluzzi L, Morselli E, Kepp O, Maiuri MC, Kroemer G. Defective autophagy control by the p53 rheostat in cancer. Cell Cycle (Georgetown, Tex.). 9: 250-5. PMID 20023384 DOI: 10.4161/Cc.9.2.10493 |
0.745 |
|
2010 |
Criollo A, Senovilla L, Authier H, Maiuri MC, Morselli E, Vitale I, Kepp O, Tasdemir E, Galluzzi L, Shen S, Tailler M, Delahaye N, Tesniere A, De Stefano D, Younes AB, et al. The IKK complex contributes to the induction of autophagy. The Embo Journal. 29: 619-31. PMID 19959994 DOI: 10.1038/Emboj.2009.364 |
0.811 |
|
2010 |
Galluzzi L, Morselli E, Kepp O, Vitale I, Rigoni A, Vacchelli E, Michaud M, Zischka H, Castedo M, Kroemer G. Mitochondrial gateways to cancer. Molecular Aspects of Medicine. 31: 1-20. PMID 19698742 DOI: 10.1016/J.Mam.2009.08.002 |
0.812 |
|
2010 |
Vitale I, Jemaá M, Senovilla L, Galluzzi L, Rello-Varona S, Métivier D, Ripoche H, Lazar V, Dessen P, Castedo M, Kroemer G. Involvement of p38α in the mitotic progression ofp53-/-tetraploid cells Cell Cycle. 9: 2895-2901. DOI: 10.4161/Cc.9.14.12254 |
0.732 |
|
2009 |
Morselli E, Galluzzi L, Kepp O, Criollo A, Maiuri MC, Tavernarakis N, Madeo F, Kroemer G. Autophagy mediates pharmacological lifespan extension by spermidine and resveratrol. Aging. 1: 961-70. PMID 20157579 |
0.712 |
|
2009 |
Kepp O, Galluzzi L, Giordanetto F, Tesniere A, Vitale I, Martins I, Schlemmer F, Adjemian S, Zitvogel L, Kroemer G. Disruption of the PP1/GADD34 complex induces calreticulin exposure. Cell Cycle (Georgetown, Tex.). 8: 3971-7. PMID 19901557 DOI: 10.4161/Cc.8.23.10191 |
0.8 |
|
2009 |
Galluzzi L, Giordanetto F, Kroemer G. Targeting HSP70 for cancer therapy. Molecular Cell. 36: 176-7. PMID 19854128 DOI: 10.1016/J.Molcel.2009.10.003 |
0.462 |
|
2009 |
Zhivotovsky B, Galluzzi L, Kepp O, Kroemer G. Adenine nucleotide translocase: a component of the phylogenetically conserved cell death machinery. Cell Death and Differentiation. 16: 1419-25. PMID 19696789 DOI: 10.1038/Cdd.2009.118 |
0.486 |
|
2009 |
Galluzzi L, Kepp O, Kroemer G. RIP kinases initiate programmed necrosis. Journal of Molecular Cell Biology. 1: 8-10. PMID 19679643 DOI: 10.1093/Jmcb/Mjp007 |
0.498 |
|
2009 |
Galluzzi L, Blomgren K, Kroemer G. Mitochondrial membrane permeabilization in neuronal injury. Nature Reviews. Neuroscience. 10: 481-94. PMID 19543220 DOI: 10.1038/Nrn2665 |
0.482 |
|
2009 |
Morselli E, Galluzzi L, Kepp O, Kroemer G. Nutlin kills cancer cells via mitochondrial p53. Cell Cycle (Georgetown, Tex.). 8: 1647-8. PMID 19448434 DOI: 10.4161/Cc.8.11.8746 |
0.706 |
|
2009 |
Boehrer S, Adès L, Tajeddine N, Hofmann WK, Kriener S, Bug G, Ottmann OG, Ruthardt M, Galluzzi L, Fouassier C, Tailler M, Olaussen KA, Gardin C, Eclache V, de Botton S, et al. Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome. Oncogene. 28: 2205-18. PMID 19398952 DOI: 10.1038/Onc.2009.69 |
0.764 |
|
2009 |
Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, Bazan NG, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Castedo M, Cidlowski JA, Ciechanover A, et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death and Differentiation. 16: 1093-107. PMID 19373242 DOI: 10.1038/Cdd.2009.44 |
0.73 |
|
2009 |
Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC, Kroemer G. Anti- and pro-tumor functions of autophagy. Biochimica Et Biophysica Acta. 1793: 1524-32. PMID 19371598 DOI: 10.1016/J.Bbamcr.2009.01.006 |
0.729 |
|
2009 |
Senovilla L, Vitale I, Galluzzi L, Vivet S, Joza N, Younes AB, Rello-Varona S, Castedo M, Kroemer G. p53 represses the polyploidization of primary mammary epithelial cells by activating apoptosis. Cell Cycle (Georgetown, Tex.). 8: 1380-5. PMID 19342895 DOI: 10.4161/Cc.8.9.8305 |
0.551 |
|
2009 |
Vicencio JM, Ortiz C, Criollo A, Jones AW, Kepp O, Galluzzi L, Joza N, Vitale I, Morselli E, Tailler M, Castedo M, Maiuri MC, Molgó J, Szabadkai G, Lavandero S, et al. The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death and Differentiation. 16: 1006-17. PMID 19325567 DOI: 10.1038/Cdd.2009.34 |
0.732 |
|
2009 |
Kepp O, Senovilla L, Galluzzi L, Panaretakis T, Tesniere A, Schlemmer F, Madeo F, Zitvogel L, Kroemer G. Viral subversion of immunogenic cell death. Cell Cycle (Georgetown, Tex.). 8: 860-9. PMID 19221507 DOI: 10.4161/Cc.8.6.7939 |
0.825 |
|
2009 |
Galluzzi L, Kroemer G. Shigella targets the mitochondrial checkpoint of programmed necrosis. Cell Host & Microbe. 5: 107-9. PMID 19218080 DOI: 10.1016/J.Chom.2009.01.002 |
0.498 |
|
2009 |
Mondragón L, Galluzzi L, Mouhamad S, Orzáez M, Vicencio JM, Vitale I, Moure A, Messeguer A, Perez-Paya E, Kroemer G. A chemical inhibitor of Apaf-1 exerts mitochondrioprotective functions and interferes with the intra-S-phase DNA damage checkpoint. Apoptosis : An International Journal On Programmed Cell Death. 14: 182-90. PMID 19152031 DOI: 10.1007/S10495-008-0310-X |
0.475 |
|
2009 |
Galluzzi L, Kroemer G. Necroptosis: a specialized pathway of programmed necrosis. Cell. 135: 1161-3. PMID 19109884 DOI: 10.1016/J.Cell.2008.12.004 |
0.418 |
|
2009 |
Galluzzi L, Morselli E, Kepp O, Kroemer G. Targeting post-mitochondrial effectors of apoptosis for neuroprotection. Biochimica Et Biophysica Acta. 1787: 402-13. PMID 18848916 DOI: 10.1016/J.Bbabio.2008.09.006 |
0.694 |
|
2009 |
Galluzzi L, Vitale I, Kepp O, Séror C, Hangen E, Perfettini JL, Modjtahedi N, Kroemer G. Methods to dissect mitochondrial membrane permeabilization in the course of apoptosis. Methods in Enzymology. 442: 355-74. PMID 18662579 DOI: 10.1016/S0076-6879(08)01418-3 |
0.504 |
|
2009 |
Boehrer S, Galluzzi L, Ades L, Fouassier C, Gardin C, Fenaux P, Kroemer G. Increased Proliferation Induced by Constitutive Activation of the Src-Kinase Lyn and Aberrant mTOR Signaling in AML Is Abrogated by the EGFR-Inhibitor Erlotinib. Blood. 114: 3813-3813. DOI: 10.1182/Blood.V114.22.3813.3813 |
0.511 |
|
2008 |
Morselli E, Tasdemir E, Maiuri MC, Galluzzi L, Kepp O, Criollo A, Vicencio JM, Soussi T, Kroemer G. Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle (Georgetown, Tex.). 7: 3056-61. PMID 18818522 DOI: 10.4161/Cc.7.19.6751 |
0.806 |
|
2008 |
Galluzzi L, Morselli E, Vicencio JM, Kepp O, Joza N, Tajeddine N, Kroemer G. Life, death and burial: multifaceted impact of autophagy. Biochemical Society Transactions. 36: 786-90. PMID 18793137 DOI: 10.1042/Bst0360786 |
0.741 |
|
2008 |
Vitale I, Senovilla L, Galluzzi L, Criollo A, Vivet S, Castedo M, Kroemer G. Chk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells. Cell Cycle (Georgetown, Tex.). 7: 1956-61. PMID 18642443 DOI: 10.4161/Cc.7.13.6073 |
0.488 |
|
2008 |
Galluzzi L, Morselli E, Kepp O, Tajeddine N, Kroemer G. Targeting p53 to mitochondria for cancer therapy. Cell Cycle (Georgetown, Tex.). 7: 1949-55. PMID 18642442 DOI: 10.4161/Cc.7.13.6222 |
0.743 |
|
2008 |
Boehrer S, Adès L, Galluzzi L, Tajeddine N, Tailler M, Gardin C, de Botton S, Fenaux P, Kroemer G. Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparison. Biochemical Pharmacology. 76: 1417-25. PMID 18617157 DOI: 10.1016/J.Bcp.2008.05.024 |
0.766 |
|
2008 |
Morselli E, Galluzzi L, Kroemer G. Mechanisms of p53-mediated mitochondrial membrane permeabilization. Cell Research. 18: 708-10. PMID 18596700 DOI: 10.1038/Cr.2008.77 |
0.67 |
|
2008 |
Hoffmann J, Vitale I, Buchmann B, Galluzzi L, Schwede W, Senovilla L, Skuballa W, Vivet S, Lichtner RB, Vicencio JM, Panaretakis T, Siemeister G, Lage H, Nanty L, Hammer S, et al. Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopilone. Cancer Research. 68: 5301-8. PMID 18593931 DOI: 10.1158/0008-5472.Can-08-0237 |
0.598 |
|
2008 |
Galluzzi L, Brenner C, Morselli E, Touat Z, Kroemer G. Viral control of mitochondrial apoptosis. Plos Pathogens. 4: e1000018. PMID 18516228 DOI: 10.1371/Journal.Ppat.1000018 |
0.716 |
|
2008 |
Galluzzi L, Kepp O, Tajeddine N, Kroemer G. Disruption of the hexokinase-VDAC complex for tumor therapy. Oncogene. 27: 4633-5. PMID 18469866 DOI: 10.1038/Onc.2008.114 |
0.539 |
|
2008 |
Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D'Amelio M, Criollo A, Morselli E, Zhu C, Harper F, Nannmark U, Samara C, Pinton P, Vicencio JM, Carnuccio R, et al. Regulation of autophagy by cytoplasmic p53. Nature Cell Biology. 10: 676-87. PMID 18454141 DOI: 10.1038/Ncb1730 |
0.825 |
|
2008 |
Vicencio JM, Galluzzi L, Tajeddine N, Ortiz C, Criollo A, Tasdemir E, Morselli E, Ben Younes A, Maiuri MC, Lavandero S, Kroemer G. Senescence, apoptosis or autophagy? When a damaged cell must decide its path--a mini-review. Gerontology. 54: 92-9. PMID 18451641 DOI: 10.1159/000129697 |
0.833 |
|
2008 |
Tasdemir E, Galluzzi L, Maiuri MC, Criollo A, Vitale I, Hangen E, Modjtahedi N, Kroemer G. Methods for assessing autophagy and autophagic cell death. Methods in Molecular Biology (Clifton, N.J.). 445: 29-76. PMID 18425442 DOI: 10.1007/978-1-59745-157-4_3 |
0.795 |
|
2008 |
Tajeddine N, Galluzzi L, Kepp O, Hangen E, Morselli E, Senovilla L, Araujo N, Pinna G, Larochette N, Zamzami N, Modjtahedi N, Harel-Bellan A, Kroemer G. Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death. Oncogene. 27: 4221-32. PMID 18362892 DOI: 10.1038/Onc.2008.63 |
0.817 |
|
2008 |
Galluzzi L, Vicencio JM, Kepp O, Tasdemir E, Maiuri MC, Kroemer G. To die or not to die: that is the autophagic question. Current Molecular Medicine. 8: 78-91. PMID 18336289 DOI: 10.2174/156652408783769616 |
0.805 |
|
2008 |
Galluzzi L, Joza N, Tasdemir E, Maiuri MC, Hengartner M, Abrams JM, Tavernarakis N, Penninger J, Madeo F, Kroemer G. No death without life: vital functions of apoptotic effectors. Cell Death and Differentiation. 15: 1113-23. PMID 18309324 DOI: 10.1038/Cdd.2008.28 |
0.788 |
|
2008 |
Pauleau AL, Galluzzi L, Scholz SR, Larochette N, Kepp O, Kroemer G. Unexpected role of the phosphate carrier in mitochondrial fragmentation. Cell Death and Differentiation. 15: 616-8. PMID 18174900 DOI: 10.1038/Sj.Cdd.4402295 |
0.384 |
|
2008 |
Boehrer S, Adès L, Braun T, Galluzzi L, Grosjean J, Fabre C, Le Roux G, Gardin C, Martin A, de Botton S, Fenaux P, Kroemer G. Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical study. Blood. 111: 2170-80. PMID 17925489 DOI: 10.1182/Blood-2007-07-100362 |
0.813 |
|
2008 |
Boehrer S, Ades L, Tajeddine N, Galluzzi L, Hofmann W, Fenaux P, Kroemer G. Selective Suppression of the DNA Damage Response in Acute Myeloid Leukemia Versus Myelodysplastic Syndrome. Blood. 112: 1656-1656. DOI: 10.1182/Blood.V112.11.1656.1656 |
0.465 |
|
2007 |
Vitale I, Galluzzi L, Vivet S, Nanty L, Dessen P, Senovilla L, Olaussen KA, Lazar V, Prudhomme M, Golsteyn RM, Castedo M, Kroemer G. Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway. Plos One. 2: e1337. PMID 18159231 DOI: 10.1371/Journal.Pone.0001337 |
0.592 |
|
2007 |
Mouhamad S, Galluzzi L, Zermati Y, Castedo M, Kroemer G. Apaf-1 Deficiency Causes Chromosomal Instability. Cell Cycle (Georgetown, Tex.). 6: 3103-3107. PMID 18073531 DOI: 10.4161/Cc.6.24.5046 |
0.523 |
|
2007 |
Zermati Y, Mouhamad S, Stergiou L, Besse B, Galluzzi L, Boehrer S, Pauleau AL, Rosselli F, D'Amelio M, Amendola R, Castedo M, Hengartner M, Soria JC, Cecconi F, Kroemer G. Nonapoptotic role for Apaf-1 in the DNA damage checkpoint. Molecular Cell. 28: 624-37. PMID 18042457 DOI: 10.1016/J.Molcel.2012.10.006 |
0.818 |
|
2007 |
de La Motte Rouge T, Galluzzi L, Olaussen KA, Zermati Y, Tasdemir E, Robert T, Ripoche H, Lazar V, Dessen P, Harper F, Pierron G, Pinna G, Araujo N, Harel-Belan A, Armand JP, et al. A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib. Cancer Research. 67: 6253-62. PMID 17616683 DOI: 10.1158/0008-5472.Can-07-0538 |
0.779 |
|
2007 |
Galluzzi L, Kroemer G. Mitochondrial apoptosis without VDAC. Nature Cell Biology. 9: 487-9. PMID 17473857 DOI: 10.1038/Ncb0507-487 |
0.47 |
|
2007 |
Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, Zitvogel L, Kroemer G. Cell death modalities: classification and pathophysiological implications. Cell Death and Differentiation. 14: 1237-43. PMID 17431418 DOI: 10.1038/Sj.Cdd.4402148 |
0.503 |
|
2007 |
Galluzzi L, Zamzami N, de La Motte Rouge T, Lemaire C, Brenner C, Kroemer G. Methods for the assessment of mitochondrial membrane permeabilization in apoptosis. Apoptosis : An International Journal On Programmed Cell Death. 12: 803-13. PMID 17294081 DOI: 10.1007/S10495-007-0720-1 |
0.683 |
|
2007 |
Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiological Reviews. 87: 99-163. PMID 17237344 DOI: 10.1152/Physrev.00013.2006 |
0.512 |
|
2007 |
Criollo A, Galluzzi L, Maiuri MC, Tasdemir E, Lavandero S, Kroemer G. Mitochondrial control of cell death induced by hyperosmotic stress. Apoptosis : An International Journal On Programmed Cell Death. 12: 3-18. PMID 17080328 DOI: 10.1007/S10495-006-0328-X |
0.801 |
|
2007 |
Galluzzi L, Karp M. Intracellular redox equilibrium and growth phase affect the performance of luciferase-based biosensors. Journal of Biotechnology. 127: 188-98. PMID 16891024 DOI: 10.1016/J.Jbiotec.2006.06.019 |
0.344 |
|
2007 |
Boehrer S, Ades L, Braun T, Galluzzi L, Grosjean J, Fabre C, Le Roux G, Gardin C, Martin A, de Botton S, Fenaux P, Kroemer G. The EGFR-Inhibitor Erlotinib Induces Differentiation, Cell Cycle Arrest and Apoptosis in EGFR-Negative Cells of MDS and AML. Blood. 110: 399-399. DOI: 10.1182/Blood.V110.11.399.399 |
0.821 |
|
2007 |
Boehrer S, Ades L, Galluzzi L, Olaussen K, Braun T, Grosjean J, Fabre C, de Botton S, Fenaux P, Kroemer G. Further Evidence That MDS and AML Cells Exhibit a Differential Capacity To Activate the DNA-Damage Response (DDR) Pathways. Blood. 110: 2438-2438. DOI: 10.1182/Blood.V110.11.2438.2438 |
0.815 |
|
2007 |
Boehrer S, Adàs L, Braun T, Galluzzi L, Grosjean J, Fabre C, de Botton S, Gardin C, Fenaux P, Kroemer G. P039 The EGFR-inhibitor erlotinib exhibits various off-target effects in MDS and AML Leukemia Research. 31: S62. DOI: 10.1016/S0145-2126(07)70109-1 |
0.755 |
|
2006 |
Galluzzi L, Larochette N, Zamzami N, Kroemer G. Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene. 25: 4812-30. PMID 16892093 DOI: 10.1038/Sj.Onc.1209598 |
0.72 |
|
2006 |
Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G. Mechanisms of cytochrome c release from mitochondria. Cell Death and Differentiation. 13: 1423-33. PMID 16676004 DOI: 10.1038/Sj.Cdd.4401950 |
0.464 |
|
2006 |
De La Motte Rouge T, Zermati Y, Galluzzi L, Armand J, Wong T, Kroemer G, Soria J. 618 POSTER A novel tyrosine kinase inhibitor exhibits significant anti-proliferative/pro-apoptotic effects in non-small cell lung cancer models European Journal of Cancer Supplements. 4: 186-187. DOI: 10.1016/S1359-6349(06)70623-1 |
0.472 |
|
2003 |
Galluzzi L, Virtanen P, Karp M. A real-time analysis of QacR-regulated multidrug resistance in Staphylococcus aureus. Biochemical and Biophysical Research Communications. 301: 24-30. PMID 12535635 DOI: 10.1016/S0006-291X(02)02992-3 |
0.316 |
|
Show low-probability matches. |